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1. Introduction 
1.1. Ascorbic acid – an overview 
1.1.1. A brief history  
During the Age of Discovery, which corresponds to years between 1500 and 1800, 
sailors spent at least 3 months continuously at the sea. Due to lack of access to fruits 
and vegetables for such long periods of time, more than 2 million sailors died of 
nutritional diseases such as beriberi, pellagra and scurvy, caused by thiamine (Vitamin 
B1), niacin (Vitamin B3) and ascorbic acid (Vitamin C) deficiency, respectively (1-3). 
Among these diseases, scurvy was the most frequently encountered one that an English 
sea captain Sir Richard Hawkins described as the ‘’plague of the sea’’ (1). Although 
captains and naval surgeons were highly convinced that citrus fruits could cure scurvy, 
most physicians denied this theory for several years (4). 
In 1907, two Norwegian physicians named Axel Holst and Theodor Frolich developed 
an interest in investigating the factors that led to a ship-related dietary disease then 
called ‘’shipboard beriberi’’ (5). In an attempt to accomplish this, they fed guinea pigs 
with a diet based on various types of grains. Although their attempts to develop beriberi 
failed; to their surprise, they observed the classical features of scurvy (5). Moreover, 
symptoms of scurvy were resolved upon addition of ‘’anti-scorbutics’’ such as fresh 
cabbage or lemon juice into their diet (5). This serendipitous discovery would open new 
horizons in Vitamin C research together with long lasting controversies over who 
deserved to be nominated for the Nobel Prize (6). In 1912, Casmir Funk, a Polish 
biochemist proposed that scurvy, beriberi, pellagra and rickets were due to dietary 
deficiencies of factors which he referred to as ‘vitamines’, a term that derived from 
‘vita’: life and ‘amine’: nitrogen containing compound (7, 8). More than a decade later, 
in 1927, a Hungarian physician named Albert Szent-Gyorgyi discovered and isolated a 
substance called ‘’hexuronic acid’’ first from the plants at Cambridge University, then 
from the adrenal gland at Mayo Clinic in Rochester, USA (9-11). Upon his return to 
Hungary, he asked Joseph Svirbely, an American-born Hungarian post-doctoral fellow 
in his lab at the University of Szeged, to test whether this crystalline compound 
protected guinea pigs from scurvy (9, 12). Svirbely’s experiments demonstrated that 
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hexuronic acid was indeed an antiscorbutic factor, today known as Vitamin C. Around 
the same time, former mentor of Svirbely, Charles Glen King and William A. Waugh 
from the University of Pittsburgh, were working on isolation and crystallization of 
Vitamin C from the lemon juice. They have subsequently demonstrated that its daily 
administration protected guinea pigs from scurvy (13, 14). This generated a bitter 
dispute over priority, which would escalate in 1937 when Szent-Gyorgyi became the 
recipient of the Nobel Prize in Physiology or Medicine, in part, for isolating Vitamin C 
(9). Not long after, Szent-Gyorgyi succeeded to extract Vitamin C samples from paprika 
peppers and sent them to Walter Norman Haworth, who was at the time a Professor of 
Chemistry at the University of Birmingham. Haworth and his group determined the 
chemical structure of Vitamin C and due to its anti-scorbutic properties, together with 
Szent-Gyorgyi, they decided to rename it as L-ascorbic acid (15-20). Subsequently, 
Vitamin C was synthesized independently by both Tadeus Reichstein in Switzerland 
and Haworth’s group in England and from that point, it could be produced on a large 
scale for medical use (16, 21). This work earned Haworth the Nobel Prize for Chemistry 
the same year with Szent-Gyorgyi. 
1.1.2. Chemistry and Biochemistry  
Ascorbic acid (L-ascorbic acid, AscH2, Vitamin C) is a ketolactone with a chemical 
formula of C6H8O6 and molecular mass of 176.12 g/mol. As a hexose sugar derivative, 
it shares a structural similarity to glucose. It is a water soluble, weak organic acid and 
has two pKa’s: pK1=4.2 and pK2=11.6 (22, 23). It is a strong reducing agent 
(antioxidant) by virtue of two enolic hydrogen atoms that it entails (24). Ascorbate 
monoanion (AscH−) is the most abundant form at physiological pH (22, 23). When 
AscH− donates a hydrogen atom (H+) or electron (e-) it forms ascorbate dianion (Asc2−) 
or neutral ascorbyl radical (AscH•), respectively (25). AscH• has a pKa of -0.86, and for 
this reason, it is present as an ascorbate radical	  (semidehydroascorbate, ascorbyl radical, 
Asc•−) at physiological conditions where pH is around 7.4 (25). Asc2− can also be 
transformed into Asc•− upon losing an e−. Asc•− is a relatively unreactive free radical and 
it can be converted back to AscH− by utilization of certain enzymes such as 
nicotinamide	   adenine dinucleotide phosphate (NADPH)-dependent thioredoxin 
reductase or nicotinamide adenine dinucleotide (NADH) dependent-cytochrome b5 
reductase. (26-30). Alternatively, two Asc•− molecules form a dimmer that undergoes a 
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series of reactions, including a reversible disproportionation (31). This results in 
generation of AscH− and dehydroascorbic acid (DHA) (26, 27, 31) (Figure 1)            
(Net reacion: 2Asc•−+H+ ⟷ AscH−+DHA). DHA can be irreversibly hydrolysed to 
2,3-diketogulonic acid but can also be recycled back to AscH− either directly by 
glutathione (GSH) itself or, by GSH or NADPH dependent enzymes such as thioredoxin 
reductase (26, 27, 32-35). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Ascorbic acid oxidation and recycling. Adapted and modified from (23). 
 
Although oxidation of ascorbic acid is a slow process, its anionic forms have variable 
rates of oxidation (36). In general, rate of oxidation depends on the pH and the presence 
of catalytic metals (37, 38). At physiological pH, AscH2 and Asc2− coexist with AscH−, 
but the total concentration of AscH2 and Asc2− is less than 0.2% (23). An increase in 
pH, leads to an increase in the amount of Asc2−, which is in turn accompanied by an 
increased rate of oxidation resulting in generaton of Asc•− and superoxide (O2•−) (38). 
Literature suggests that true autoxidation of AscH− is indeed very slow and according to 
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Williams and Yandell, Asc2− is the only Vitamin C species, which would go through a 
significant autoxidation (36, 38).  
1.1.3. Absorption, Cellular Uptake and Excretion  
Through evolution, humans lost their capacity to synthesize ascorbic acid de novo. This 
is due to a mutation in L-gulono-γ-lactone oxidase gene, which encodes L-gulono-γ -
lactone oxidase enzyme that is required for the last step of ascorbic acid synthesis (39). 
Hence, we are dependent on the dietary intake for obtaining adequate amounts of this 
essential vitamin. Upon ingestion, ascorbic acid is absorbed through the brush border 
cells of the small intestine. This takes place via two major mechanisms; such that 
ascorbate is taken up via Na+-dependent Vitamin C transporters (SVCT) and its two-
electron-oxidized form DHA is taken up via facilitative glucose transporters (GLUT), 
mainly GLUT1 and GLUT 3 (40-43).  
Two isoforms of SVCT mediate the transport of ascorbate; SVCT1 and SVCT2. 
SVCT1, commonly called the ‘’bulk transporter’’, resides largely in apical brush border 
membranes of enterocytes and renal tubular cells, which are responsible for absorption 
and re-absorption, respectively (42, 44, 45). SVCT2 has a broader distribution and can 
be found in osteoblasts, platelets, cardiac, neural, neuroendocrine, exocrine and 
endothelial tissues (42, 45, 46). SVCT2’s activity seems to be crucial for protection 
against oxidative injury (47, 48). Unlike most tissues, epidermal cells express both 
SVCT1 and SVCT2 while dermal cells express SVCT2 only (49). Bioavailability of 
ascorbate is tightly controlled via regulation of SVCT expression. For example, when 
its levels are elevated in the intestinal lumen, SVCT1 is downregulated in enterocytes 
(50). Similarly, when intracellular ascorbate levels are reduced in lung epithelial cells, 
SVCT2 expression is increased (51). In vitro and in vivo studies have shown that 
hormones, paracrine factors, oxidative stress and intracellular signaling molecules also 
play a role in regulation of expression of SVCT (47, 52-54).  
Affinity of GLUT to DHA is relatively low when compared to SVCT’s affinity for 
ascorbate (41, 55). Once DHA enters the cells, it is then immediately converted to 
ascorbate (41). However, there are exceptions to this case; for instance oxidative stress 
may hamper the accumulation of intracellular ascorbate from DHA (56). Presence of 
glucose may influence DHA uptake, as they compete for the same GLUT transporters, 
but this phenomenon varies between cell types (41, 56-60). Although through a 
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different mechanism, Na+ dependent ascorbate transport was also shown to be 
modulated by glucose (55, 61). In addition to an endocrine regulated DHA transport, 
modulatory effects of intracellular signaling molecules and oxidative stress on DHA 
uptake have also been reported (53, 59, 62). However, it must be noted that SVCT and 
GLUT transporters may respond differently to the same hormone or cytokine. An 
intriguing example is the regulatory effects of transforming growth factor-β (TGF-β) on 
osteoblastic cells (63). While an increased rate of Na+-ascorbate cotransport activity is 
induced by TGF-β, no changes in DHA levels were observed in the same cells (63). 
Amount of Vitamin C that is absorbed and excreted depends mainly on the intake, 
bioavailability, metabolism and the route of administration. In a study by Levine et al., a 
steep curve was observed between 30-100 mg daily doses whereas complete plasma 
saturation was reached at 1000 mg (64). Likewise, urinary excretion was only observed 
at and above 100 mg and, at a single dose of 500 mg or higher, although partially 
absorbed, Vitamin C was substantially excreted (64). Nevertheless, Padayatty et al. 
demonstrated that, one can achieve a higher Vitamin C concentration in plasma, by 
delivering it intravenously rather than orally (65). In healthy adults, plasma 
concentration of ascorbic acid is usually in the range of 15-90 µmol (65-68). On the 
other hand, tissue concentrations vary depending on the tissue and cell type (68-72). For 
instance, average ascorbic acid contents of adrenal and pituitary gland were reported as 
30-40 mg/100g and 40-50 mg/100g, respectively, while that of skeletal muscle was 
found to be only 3 mg/100g (69, 72).  
Excretion of Vitamin C occurs via filtration and tubular reabsorption (73). However, 
when Vitamin C is presented to the tubules at a rate that is above the maximal rate of 
tubular reabsorption, excess Vitamin C is excreted in the urine (73). Pathologic 
conditions may alter stored and excreted levels of ascorbic acid (67, 74, 75). Spellberg 
and Keeton compared the levels of ascorbic acid excreted in healthy persons and cancer 
patients (75). They found that after a 400 mg daily ascorbic acid administration, first 
group excreted 56 to 80% of intake, whereas the latter excreted only 34 to 48% (75). 
This may be due to metabolic differences in healthy and cancer tissues, which seem to 
be reflected by lower plasma levels of ascorbic acid in cancer patients (67, 76, 77). 
Klimant and collegues also propose that a high level of Vitamin C consumption in 
certain pathological conditions is in part compensated by reduced rate of excretion by 
the kidneys (67). 
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As mentioned in the previous chapter, a fraction of DHA is irreversibly converted to 
2,3-diketogulonic acid (27, 78). This metabolite can further be degraded into l-
erythrulose and oxalate (79). It has been shown that oxalate excretion increases with 
high ascorbic acid intake (64). When further epidemiological evidence presented in the 
literature is taken into consideration, high levels of ascorbic acid seem to constitute a 
risk for oxalate nephropathy, especially when the renal function have been 
compromised (80-82). 
1.1.4. Functions  
Ascorbic acid is involved in several fundamental physiological and biochemical 
processes. Its major and probably the most important role lies in its property as an 
antioxidant (83). AscH− readily gives an electron to free radicals such as hydroxyl 
radical (HO•), O2•−, peroxyl radical, thiol radical, sulphur radicals and tocopheroxyl 
radical at the expense of generating an Asc•−. 
    AscH− + X• → Asc•− + XH 
Aside from its antioxidant activities, it is required as a co-factor in synthesis of 
norepinephrine, serotonin, tyrosine, homogentisic acid, carnitine, hydroxylysine and 
hydroxyproline. Moreover, it amidates peptides for hormone activation, mediates nitric 
oxide synthase and hypoxia-inducible transcription factor (HIF) activity, and assists iron 
absorption in the small intestine (26, 44, 78).  
Two amino acids, proline and lysine are among the key components of collagen 
formation process. Proline needs to be hydroxylated to generate a more stable triple-
helical structure of collagen (84). On the other hand, hydroxylysine not only acts as a 
precursor of the intra- and inter-molecular crosslinking process which gives collagen its 
tensile strength, but also facilitates the glycosylation process by serving as an 
attachment site for galactose and glucosylgalactose (85, 86). Hydroxylation of selective 
proline residues occurs by collagen prolyl-4-hydroxylase and prolyl-3-hydroxylase 
while lysine residues are hydroxylated by lysyl-hydroxylase (84). These three enzymes 
and γ-butyrobetaine dioxygenase and trimethylhydroxylase which catalyze the 
formation of L-carnitine, together with HIF prolyl-4- and asparaginyl- hydroxylases 
which suppress HIF-1 activity, belong to the family of 2-oxoglutarate and Fe2+-
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dependent dioxygenases and require ascorbate either as a co-substrate or to recycle Fe3+ 
back to Fe2+ (23, 78, 87-90). Likewise, norepinephrine is synthesized by a copper-
containing oxygenase, so called dopamine β-hydroxylase and it does require ascorbate 
as a co-factor (91).  
Hormones and hormone-releasing factors such as gastrin, oxytocin, vasopressin, 
corticotropin, thyrotropin are initially synthesized as larger, inactive precursor 
molecules. They need to go through series of post-transitional modifications, to be 
converted to their active forms. The last step in this process is carboxyl-terminal α-
amidation, which utilizes peptidyl glycine α-hydroxylating monooxygenase, an enzyme 
that is also dependent on O2, Cu+ and ascorbate (92, 93).  
Tetrahydrobiopterin, a folic acid derivative, is a co-factor of several enzymes, including 
nitric oxide synthase, phenylalanine, tyrosine and tryptophan hydroxylase (94-97). 
However, its plays a slightly different role for nitric oxide synthase in comparison with 
other enzymes (97). Binding of tetrahydrobiopterin to nitric oxide synthase, enables 
synthesis of nitric oxide (NO) (98). On the other hand, it gets rapidly oxidized to a 
short-lived intermediate, quinoid dihydrobiopterin, which then rearranges to 
dihydrobiopterin (98). As	  opposed to tetrahydrobiopterin, dihydrobiopterin inhibits NO 
formation and instead leads to O2•− generation (98). Ascorbate as a reducing agent and 
an antioxidant is able to maintain tetrahydrobiopterin in its reduced state (98, 99). In 
case of tyrosine, ascorbate is required for its catabolism (100). On the other hand, 
phenylalanine hydroxylase, an iron containing enzyme that catalyses the conversion of 
L-phenylalanine to L-tyrosine, requires, O2 and tetrahydrobiopterin as an electron 
carrier (101). During this process, tetrahydrobiopterin gets oxidized and an NADPH 
dependent enzyme so called dihydrobiopterin reductase recycles the oxidized form back 
to tetrahydrobiopterin. Stone and Townsley suggested that presence of ascorbate could 
also contribute to this recycling process (96). 
Iron ingested from food presents in two forms; heme and nonheme iron. Heme, contains 
iron in ferrous (Fe2+) form, and it is derived from hemoglobin and myoglobin, found in 
meat, poultry and fish. Nonheme iron, which exists in ferric (Fe3+) state, is present in 
plant-based foods such as fruits and vegetables. It is known that dissociation of ferric 
compounds (eg. hydroxide, phosphates, complexes such as iron tannate) are much less 
than those of ferrous ones (102, 103). One of the key roles of ascorbate in iron 
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metabolism is that it promotes dietary nonheme iron absorption by reducing Fe3+ to Fe2+ 
together with duodenal cytochrome b reductase (103). An iron binding plasma 
glycoprotein, called transferrin, facilitates transport of iron through the bloodstream. 
Although to a lesser extent, non-transferrin bound iron (NTBI) can also occur in the 
circulation (104). In order to bind transferrin, iron in ferrous form needs to be oxidized 
to Fe3+ by hephaestin (104).  
Almost all cells acquire most of their iron from the serum iron-carrier protein 
transferrin, but they are also capable of importing it in the form of NTBI (104). The 
latter occurs through divalent metal transporter 1 (DMT1) and requires reduction of Fe3+ 
to Fe2+ (105, 106). This reduction occurs via release of ascorbate from the cytoplasm 
into the extracellular space (104-106). However, in case of transferrin dependent iron 
uptake, ascorbate can facilitate the uptake via an intracellular reductive mechanism,	  
which follows a transferrin receptor dependent endocytosis of di-ferric transferrin 
complexes (104, 107). Once this	  complex is located inside the endosome, the endosome 
becomes acidified and enables release of Fe3+ from transferrin. A subsequent 
ferrireduction is followed by the release of iron, which then gets transported by DMT1 
and/or Zip14 (104, 107). In addition to these properties, studies show that ascorbate is 
likely to further modulate iron metabolism by increasing the expression of the gene for 
the iron storage protein, ferritin, enhancing iron deposition, inhibiting lysosomal ferritin 
degradation and reducing iron efflux (104, 107).  
Concentration of ascorbic acid in skin is relatively high when compared to other tissues 
(70, 108-110). In addition to dual expression of SVCT (SVCT1 and SVCT2) in the skin 
epidermis, there is also a 2 to 5 fold difference between the ascorbic acid content of the 
epidermis and dermis (49, 108-109). These findings suggest a high dependency on 
ascorbic acid, especially in the epidermis. There is growing evidence showing that 
ascorbic acid may play a role in differentiation of keratinocytes and formation of 
stratum corneum barrier lipids (111-113). In an in vitro study, Pasonen-Seppanen and 
collegues demonstrated that ascorbic acid improved stratum corneum structure, 
increased keratohyalin granules and the intercellular lipid lamellae present in the 
interstices of the stratum corneum (111). Extracellular matrix (ECM), which is an 
important component of connective tissue, entails two groups of biomolecules; 
glycosaminoglycans and fibrous proteins such as collagen, elastin, fibronectin and 
laminin. In this context, ascorbic acid and its derivatives were shown to increase 
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glycosaminoglycan synthesis, its deposition into the ECM and stimulate elastin (114, 
115). Duarte et al. assessed the effect of ascorbic acid 2-phosphate, a more stable 
derivative of ascorbic acid, on gene expression in primary dermal fibroblasts and found 
an increase in expression of various genes that are involved in cell motility, matrix 
remodeling during wound healing, deoxyribonucleic acid (DNA) replication and repair 
(116). In agreement with these findings, several in vivo and clinical studies 
demonstrated that ascorbic acid plays a key role in wound healing (117-119). Protein 
and DNA damage induced by ultraviolet (UV) radiation is one of the leading causes of 
photoaging and photocarcinogenesis. Although cutaneous damage caused by UV 
radiation is a complex process, one of the proposed mechanisms of action for generation 
of UV damage is a possible reaction between UV induced hydrogen peroxide (H2O2) 
and metal ions that are already bound to DNA and, a	   subsequent generation of HO• 
(120, 121).  A second proposed pathway is the lipid peroxidation of membranes caused 
by UV induced free radicals, which in turn may cause mutagenesis and cell death (121, 
122). Ascorbic acid seems to ameliorate the damaging effects of UV both as a free 
radical scavenger and as an inducer of DNA repair and regeneration genes (122-128). 
Increased consumption of ascorbic acid in such cases is likely to be compensated by an 
increased uptake by keratinocytes in an irradiation time and dose dependent manner 
(129). However, according to the current literature, in the context of modulation of UV 
induced skin damage, benefits of ascorbic acid alone is limited and satisfactory results 
can be achieved only when it is combined with two or more antioxidants (130-132). 
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1.2. Oxidative stress, antioxidants and prooxidants 
1.2.1. Oxidative stress 
A free radical is a reactive molecule that has an unpaired electron in its outer orbit. It 
may derive from endogenous metabolic processes, enzymatic systems or from external 
sources such as ionizing radiation, pathogens, drugs and chemicals. Free radicals tend to 
steal an electron from a surrounding molecule, which leaves the other molecule as a free 
radical with an unpaired electron. This may lead to a chain of reactions and result in 
cellular damage. Free radicals can bind to DNA bases and modify nucleotides, or cause 
DNA strand breaks via reacting with the 5-carbon sugar deoxyribose (121, 133). They 
can also oxidize thiol groups in cysteine residues and cause formation of a disulfide 
bond, which can alter the protein structure and function (134). Two hydrogen atoms 
(H+) that exist between the two double bonds of polyunsaturated fatty acids are highly 
prone to being targets of free radicals. Lipid peroxidation that is initiated by a reaction 
between one of these hydrogen atoms and an oxidizing agent such as HO• or iron-
oxygen complex (perferryl or ferryl ion), leads to a cascade of events, resulting in 
formation of new radicals and a number of compounds such as; lipid alkyl radical, lipid 
peroxyl radical, lipid hydroperoxide, malondialdehyde and 4-hydroxy-2-noneal, that can 
in turn cause cellular damage (135, 136). Availablity of sufficient O2 is crucial during 
the propagation stage, as the newly generated lipid alkyl radical needs to react with O2 
to form a lipid peroxyl radical, which will then steal a hydrogen atom to generate lipid 
hydroperoxide and a new lipid alkyl radical to continue the process. Among other 
enzymes, glutathione peroxidase seems to be the key enzyme that is shown to protect 
cells from the lipid peroxidation process and their effects (137, 138).  
Molecular oxygen (O2) has two unpaired electrons and therefore it is a biradical. It 
readily accepts unpaired electrons and gives rise to a variety of partially reduced species 
named as reactive oxygen species (ROS). These include O2•−, HO•, peroxyl radical and 
alkoxyl radical. The cellular damage caused by ROS is termed oxidative stress. One-
electron reduction of O2 to O2•− can occur by various processes such as mitochondrial 
electron transport by complex I and complex III, UVB induced type I photosensitizing 
reactions with internal chromophores, by NADPH oxidase, which gets activated by 
UVB exposure and found mainly in neutrophils, and by nitric oxide synthase as well as 
xanthine oxidase activity (139-142). O2•− can react with another free radical, NO to form 
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peroxynitrite, a highly reactive intermediate which can damage a wide range of 
molecules in cells (143, 144). In an attempt to convert O2•− into less damaging species, 
superoxide dismutase catalyzes the dismutation of two molecules of O2•− into O2 and 
H2O2. Although H2O2 is not a free radical, it is a potent oxidant and it does contribute to 
generation of free radicals. This can occur via formation of hypochlorous acid (HOCl), 
a precursor of free radicals, by an enzyme called myeloperoxidase, by Fenton and 
Haber-Weiss reactions (Figure 2) or by various cyclical transition metal ion catalyzed 
redox reactions which all gives rise to HO•, the foremost reactive ROS (139, 145-147). 
In an attempt to diminish potential harmful effects of H2O2, the heme-containing 
enzyme catalase and glutathione peroxidase participate in decomposition of H2O2 to 
H2O (148). In addition to HO• generation from H2O2, H2O exposed to ionizing radiation 
may also lead to formation of HO• and GSH plays an important role in its elimination 
(146).  
  
2 O2•− + 2 H+ → H2O2 + O2 
   Fe3+ + O2•− ⇌ Fe2+ + O2     
   Fe2+ + H2O2 → Fe3+ + HO• + OH−     Fenton Reaction   
   O2•− + H2O2 → O2 + HO• + OH−     Haber Weiss Reaction 
  
Figure 2: Fenton and Haber Weiss reactions (149-151).  
 
1.2.2. Antioxidants 
Normal physiological processes such as aerobic respiration continuously generate free 
radicals and oxidants and, when produced in moderate amounts, they play important 
roles in the regulation of intracellular signal transduction pathways, host defense system 
and immunity (152-157). Additionally, they are essential for a variety of catabolic and 
anabolic processes to take place. However, each cell maintains a homeostasis between 
prooxidant and antioxidant species and when there is an imbalance between the two, 
pathological processes ensue (139, 152, 158, 159).  
Halliwell and Gutteridge first defined antioxidants in 1995 as ‘’any substance that, 
when present at low concentrations compared with those of an oxidizable substrate, 
significantly delays or prevents oxidation of that substrate’’ (160) but this definition 
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was later simplified and re-defined as  ‘’any substance that delays, prevents or removes 
oxidative damage to a target molecule’’ (161, 162). Recently, Apak and collegues came 
up with a slightly different and more detailed definition and defined antioxidants as  
‘’natural or synthetic substances that may prevent or delay oxidative cell damage caused 
by physiological oxidants having distinctly positive reduction potentials, covering 
ROS/reactive nitrogen species (RNS) and free radicals (i.e. unstable molecules or ions 
having unpaired electrons)’’ (163). However, a property that was not emphasized in 
these definitions is the ability of an antioxidant, which scavengers the radical, to 
generate a new radical which is stable through intramolecular hydrogen bonding upon 
further oxidation (152, 164). Moreover, substances which up-regulate antioxidant 
defenses may also qualify as antioxidants.  
Antioxidant system is classified into two major categories; enzymatic and non-
enzymatic antioxidants. Enzymatic antioxidants, such as superoxide dismutase, catalase 
and glutathione peroxidase prevent formation of ROS or reduce ones that have already 
been generated. For instance, glutathione peroxidase catalyses the reduction of H2O2 by 
two reduced glutathione (GSH) which leads to generation of oxidized glutathione 
(glutathione disulfide, GSSG) and two H2O (165). Regeneration of GSH from GSSG 
requires glutathione reductase as an enzyme and NADPH as an electron donor (165). In 
fact, many enzymes of the antioxidant system depend on NADPH for proper function 
and glucose-6-phosphate dehydrogenase acts as a major supplier for this intracellular 
reductant (166, 167). Therefore, both GSH/GSSG as well as NAD(P)H/NAD(P)+ ratios 
are considered to be important indicators of redox status of cells (166, 168, 169). 
Non-enzymatic antioxidants are also categorized into two groups; endogenous 
antioxidants such as Vitamin A, Vitamin C and E, ubiquinol, carotenoids, urate, GSH, 
flavonoids, NAD(P)H, and synthetic antioxidants, which include butylated 
hydroxytoluene and butylated hydroxyanisole (152, 170).  
α- and β-carotene, cryptoxanthin and lycopene, are the main carotenoids. Among these, 
β-carotene has a major role in Vitamin A formation by virtue of an enzyme called β, β-
carotene-15, 15′ monooxygenase which catalyzes the centric cleavage of β-carotene to 
yield all-trans-retinal (171). All-trans-retinal can then be reduced to all-trans-retinol 
(Vitamin A) by retinol dehydrogenase (172, 173). Vitamin A and carotenoids’ 
antioxidant properties lie in their ability to quench singlet oxygen (1O2), neutralize thiyl 
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radicals, and combine with peroxyl radicals to protect cells from lipid peroxidation 
(173, 174). α-Tocopherol, the most dominant isoform of Vitamin E, exerts its main 
antioxidant effect by donating phenolic hydrogen to the peroxyl radicals, which in turn 
generate tocopheroxyl radicals (152, 175). This process protects cells from lipid 
peroxidation and consecutively maintains membrane integrity. In order to provide 
continuous supply and eliminate the newly generated radical, Vitamin E is recycled 
from its tocopheroxyl radical either by enzymes such as NADH-cytochrome b5 
reductase or by nonenzymatic pathways, which utilize compounds such as AscH− and 
ubiquinol (176-180).  
Glutathione is a tripeptide (cysteine, glycine, and glutamic acid) with a redox-active 
thiol group that generally exists in cells in its reduced state (GSH) (165). When GSH 
donates a hydrogen atom to a free radical intermediate, it is converted into a glutathiyl 
radical, which may react with a variety of species depending on the circumstances (181-
183). For instance, glutathiyl radical can enter an electron transfer reaction with AscH− 
to generate GS− and Asc•− (183). Glutathione also contributes to the detoxification 
process by conjugating with a plethora of reactive metabolites and reacting with 
electrophiles that are generated as a result of metabolic processes (165). Additionally, it 
facilitates recycling of Vitamins C and E from their oxidized forms and in turn increases 
availability of antioxidants (169). 
Phenols are aromatic compounds that contain an –OH group attached to a benzene ring. 
Phenols, which have more than two aromatic –OH groups, are termed as polyphenols. 
Almost all phenols exert a degree of antioxidant activity as scavengers of reactive 
species such as peroxyl radical, HO• and HOCl. Some also serve as chelating agents by 
binding transition metal ions, which further reduces oxidative stress (184, 185). 
Polyphenols are further classified according to the number of phenol rings they 
accommodate and the structures that bind these rings to one another. According to these 
properties, they are divided into four major categories; Phenolic acids, flavonoids, 
stilbenes, and lignans (186). Among these, more attention has been given to flavonoids. 
Flavonoids consist of a fifteen-carbon skeleton that entails two benzene rings (A and B) 
linked by three carbon atoms that usually form a third oxygenated heterocyclic ring (C) 
(187). In majority of cases, B ring is attached to C ring in the 2-position but this may 
differ among different types of flavonoids such as isoflavones and neoflavonoids. Those 
in which B ring is linked in position 2 are further subclassified according to the 
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structural features of the C ring and include flavonols, flavones, flavanones, flavanols, 
flavanonols, catechins, anthocyanins (186). Flavonoids owe some of their antioxidant 
properties to the phenolic hydroxyl groups attached to ring structures, which can serve 
as reducing agents, hydrogen donors, O2•− scavengers and 1O2 quenchers (188-190). 
Furthermore, specific ones serve as chelators of iron and copper, inhibitors of oxidases 
such as xhanthine oxidase and NADH oxidase and activators of detoxifying enzymes 
such as glutathione S-transferase (190, 191). Some can also replace antioxidant activity 
of α-tocopherol in the membrane, reduce α-tocopheryl radicals and regenerate α-
tocopherol (190, 192-194). 
Coenzyme Q is an endogenously synthesized lipid soluble substance that participates in 
the mitochondrial respiratory chain as an electron carrier (195). Ubiquinone and 
ubiquinol are the predominant oxidized and reduced forms of Coenzyme Q, respectively 
(196). Reduction of ubiquinone to ubiquinol occurs by a variety of oxidoreductases such 
as Complex I, Complex II, electron transfer flavoprotein-ubiquinone oxidoreductase, 
and non-proton pumping NADH dehydrogenases (in yeast) (196). In mammalian cells, 
reoxidation of ubiquinol to ubiquinone occurs only by Complex III, whereas in case of 
yeast, alternative oxidases also take part in the process (196). Ubiquinol is an effective 
antioxidant. Studies show that it prevents lipid peroxidation, takes part it regeneration of 
Vitamin E from the α-tocopheroxyl radical and halts oxidation of membrane proteins 
(180, 195-199).  
1.2.3. Prooxidant properties of antioxidants 
There is already substantial evidence that antioxidants play a major role in metabolic 
pathways and protect cells from the harmful effects of reactive species. However, some 
of the antioxidants can also exhibit prooxidant effects (200, 201). Whether an 
antioxidant behaves as a prooxidant seems to depend on multiple factors such as its 
concentration, cellular redox state, availability of other antioxidants and, the presence 
and amount of O2, catalytic metal ions and radicals. For instance, green tea polyphenol 
(-)-epigallocatechin-3-gallate was shown to generate HO• and O2•− and cause cleavage 
of DNA in the presence of Cu2+ (202). In a study by Palozza et al., β-carotene when 
tested at high concentrations, increased generation of ROS in leukemia cells (203). 
Moreover, retardation of cell cycle progression and proapoptotic activity highly 
coincided with increased ROS levels (203). These effects were reversed when low 
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concentrations were applied. The authors further assessed the variations in response to 
β-carotene in differentiated and undifferentiated leukemia cells and found that increase 
in ROS generation was observed at lower concentrations in undifferentiated cells when 
compared to differentiated ones. Likewise, post-treatment levels of GSH were higher in 
differentiated cells than those that are undifferentiated (203). Certain flavonoids, which 
act as powerful antioxidants, when tested at high concentrations, were shown to 
generate ROS, induce DNA strand breaks, oligonucleosomal fragmentation as well as 
caspase-3 activation (201, 204-206). However, sometimes it is challenging to 
distinguish an antioxidant dose range from a prooxidant dose range.  For example, while 
fisetin, a plant polyphenol from the flavonoid group, at 22 µmol/L could protect cells 
from DNA strand breaks caused by H2O2, it could itself induce DNA strand breaks 
when H2O2 is absent (206). There is also some uncertainty about how flavonoids exert 
their cytotoxic and DNA damaging effects. Watjen et al. (206) found no indication for 
metal-catalysed oxidation, lipid peroxidation and ROS involvement whereas Sahu et al. 
(207) demonstrated that in the presence of transition metal ions, ROS and mainly HO• 
was responsible for lipid peroxidation and the DNA damage caused by quercetin. 
Duthie and colleagues observed DNA strand breaks as well as a decrease in GSH levels, 
however they found no evidence for oxidative DNA base damage (208). It might very 
well be possible that nucleus was protected from ROS at the expense of intracellular 
GSH (208). Agullo and co-workers argued that degree of quercetin cytotoxicity was 
dependent on cellular proliferative activity, and this selective cytotoxicity could be 
utilized to inhibit growth in tumor cells (209). The group observed a diminished lactate 
release in dividing cells, which was likely to be caused by its inhibitory action on lactate 
transporter (209, 210). Nevertheless, a dramatic reduction in levels of adenosine 
triphosphate (ATP) was observed for both exponentially growing and stationary 
growing human colonic carcinoma cells (209). DNA topoisomerases play a role in DNA 
replication, transcription, and recombination by introducing transient breaks in the 
DNA. These enzymes also act to regulate DNA supercoiling generated during 
transcriptional elongation (211). Evidence suggests that some flavonoids such as 
myricetin, quercetin and fisetin can inhibit topoisomerase II (212, 213). This may arrest 
cell cycle and induce apoptosis via a p53 dependent or independent pathway (201, 213, 
214). Selected flavonoids can also exhibit antimicrobial activity (215). One example is 
quercetin, which was shown to demonstrate antibacterial activity by inhibiting gyrase 
catalyzed DNA isomerization (216). Some studies also proposed that specific 
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antioxidants exert their prooxidant effects through inhibition of cellular respiration. 
Pavani et al. reported that nordihydroguaiaretic acid, a polyhydroxyphenolic 
antioxidant, acts as an inhibitor of mitochondrial electron transport, by interrupting the 
flow of electrons at the NADH-dehydrogenase-ubiquinone compartment of ascites 
tumor cells (217). A consequential decrease in ATP synthesis led to decreased cell 
viability and growth rates in the same cells (217). Several other phenols were also 
shown to inhibit mitochondrial electron flow at different sites and/or uncouple redox 
reactions from that of adenosine diphosphate (ADP) phosphorylation (218-221). 
Capsinoids, which possess antioxidant properties mainly via forming complexes with 
the reduced metals and donating H+ to radical intermediates, can protect cells from iron-
mediated lipid peroxidation and copper-dependent oxidation of low-density lipoproteins 
(222-224). Studies showed that some of its analogues may also exert selective 
prooxidant effects via preferentially inhibiting NADH oxidase activity in the plasma 
membrane of cancer cells. This inhibition was accompanied by an inhibition of growth 
and, apoptosis (225, 226). Furthermore, when HL-60 human promyelocytic leukemia 
cells were induced to differentiate, capsaicin’s effect on the plasma membrane NADH 
oxidase activity was much less (225). Morre and colleagues further suggested that in 
capsaicin resistant cases, selective inhibition of NADH oxidase activity and subsequent 
inhibition of growth could be achieved with co-administration of mild oxidizing agents 
such as H2O2 and t-butyl hydroperoxide (226). These findings indicate that modification 
of redox state may be considered as an alternative approach for cancer types that do not 
respond to therapy.  
1.2.3.4. Vitamin C as a prooxidant 
Ascorbic acid, as an electron donor, gained most of its popularity through its antioxidant 
effects (83). However it may also act as a prooxidant, at pharmacologic doses (P-Asc) 
when specific conditions [eg. Kirsten rat sarcoma viral oncogene (KRAS) positivity] are 
met (23, 227). Literature suggests that P-Asc can exert selective toxicity against some 
tumor cells and infectious microorganisms (23, 227-229). Nevertheless, these effects 
remain controversial for various reasons such as fundamental differences between in 
vitro and in vivo conditions, lack of understanding of the exact mechanism of action and 
scarce clinical data that supports its efficacy.  
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The most well accepted mechanism of action of P-Asc has been linked to its ability to 
generate H2O2 (228, 230, 231). It is already well known that AscH− reduces Fe3+ to Fe2+ 
at the expense of producing an Asc•− (229). A subsequent reaction of Fe2+ with O2 
generates Fe3+ and O2•− (229). H2O2 is then formed via dismutation of two molecules of 
O2•−. A reaction between the newly generated H2O2 and Fe2+ leads to formation of HO• 
and Fe3+ (Fenton reaction) (Figure 1). AscH− can further reduce Fe3+ back to Fe2+ for 
the cycle to continue. Studies have demonstrated that levels of antioxidant enzymes 
differ across tissues and among certain cancer cells versus normal ones (232, 233). Low 
levels of catalase and glutathione peroxidase detected in a variety of cancer cells renders 
them especially vulnerable to H2O2, and indirectly to P-Asc (233). According to Doskey 
and colleagues, this vulnerability also varies among different tumor cell types because 
not all cell types possess same degree of catalase activity (230). Nevertheless, 
mechanisms for how H2O2 elicited by P-Asc, induces toxicity to tumor cells are still 
under investigation. Some studies suggest that poly (ADP-ribose) polymerase (PARP) 
activation through H2O2 induced DNA damage may lead to catabolization of NAD+, 
which could in turn deplete the substrate for NADH formation and hinder ATP 
synthesis (234-236). In the process of disposing H2O2 by an NADPH-dependent 
glutathione reductase/peroxidase system, NADPH is utilized to reduce GSSG back to 
GSH. In order to replenish NADPH that is consumed during this process, some of the 
glucose that is used for glycolysis could be diverted to the pentose phosphate pathway 
that in turn would result in reduction of ATP synthesis (234, 236). H2O2 induced 
inhibition of glycolysis by inactivation of glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) is assumed to further decrease NADH production and generation of ATP 
(236, 237). Also, at the level of mitochondria, inhibition of ATP synthase by H2O2 
exposure appears to interrupt ADP phosphorylation and in turn ATP production (237, 
238). However, findings by Du et al. were not in full alignment with some of these 
hypotheses (231). Although the group agrees that decreased cell viability caused by P-
Asc is via a H2O2 mediated mechanism, they also indicate that PARP activation and 
depletion of ATP may not be involved in P-Asc induced cytotoxicity. Their experiments 
rather suggest that P-Asc’s effects are through a caspase-independent cell death 
mechanism that is associated with autophagy (231).  
‘’Warburg Effect’’ first described by Otto Warburg refers to the phenomenon that, in 
tumor and other proliferating cells, there is an increased rate of glucose uptake and, 
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even in aerobic conditions, fermentation and subsequent production of lactate is 
preferred over oxidative phosphorylation (239-243). This preference towards a less 
efficient pathway for ATP synthesis was initially attributed to defective mitochondria 
(241). On the other hand, some more recent studies disputed this hypothesis and 
suggested that cancer cells heavily engage in both glycolysis and oxidative 
phosphorylation in order to be able to generate sufficient levels of ATP and NADPH 
but also to synthesize nucleotides and amino acids, which are all crucial for cell 
proliferation (244, 245). Lately, it has been further elaborated that under certain 
circumstances tumors can exert a metabolic plasticity to maintain growth and survival 
(246). One example is melanocyte lineage-specification transcription factor (MITF) 
upregulated proliferator-activated receptor-gamma coactivator-1alpha (PGC1α) positive 
melanomas, which are highly dependent on oxidative phosphorylation rather than 
glycolysis (247). Contrarily, an activated BRAF mutation leads to suppression of 
oxidative phosphorylation and induces a glycolytic phenotype (248). Moreover, 
evidence suggests that tumor microenvironment is heterogeneous (249). For instance, 
centers of solid tumors are generally poorly perfused lacking sufficient glucose and O2 
supply. Therefore, metabolic activity may also vary within the tumor itself. On the other 
hand, some authors argue that when tumor microenvironment is hypoxic, HIF-1 gets 
activated which in turn induces enzymes involved in glycolysis, upregulate GLUT 
transporters, reduce mitochondrial function to save O2 and in turn reliance on glycolysis 
becomes more pronounced (239). This process is further enhanced via a positive 
feedback loop between glucose metabolites and HIF-1 (239, 250). Apart from hypoxia, 
HIF-1 can also be activated by other factors such as activation of Ras oncogene or loss 
of tumor suppressor von Hippel-Lindau (VHL) which all lead to a tendency of tumor 
cells to shift energy production towards glycolysis, even under normoxic conditions 
(239). Taken together, it seems that tumor cells tend to heavily depend on glycolysis 
despite the presence of a functional mitochondria but when the circumstances change, a 
metabolic switch is likely to occur. Consistent with this phenomenon, studies show that 
majority of tumors significantly upregulate GLUT to meet the glucose demands for 
increased glycolysis (251-253). Considering that specific GLUT channels are also 
responsible for transporting DHA across cellular membranes, one would expect a higher 
uptake of DHA by the tumor cells. Based on this assumption, Yun and collegues tested 
the effect of P-Asc on KRAS and BRAF mutant colorectal cancer cells that are 
associated with glycolytic phenotype. The group reported an increased DHA uptake 
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associated with upregulation of GLUT-1 transporter and elevated levels of oxidative 
stress caused by depletion of GSH during the conversion of DHA to its reduced form 
(236). Their study further revealed that GAPDH activity and consequently glycolysis 
were inhibited by ROS induced pentose posphate pathway activity as well as PARP 
activation, which leads to diminished level of NAD+, the substrate required for 
GAPDH. These chain of events resulted in depletion of ATP, cellular energy crisis and 
cell death (236). Spielholz et al. demonstrated that melanoma cell lines take up DHA at 
a rate that is at least 10 times greater than normal melanocytes (254). Subsequently, 
Corti and colleagues (255) documented that, in the presence of iron, gamma-
glutamyltranspeptidase, a plasma membrane enzyme that is often highly expressed in 
human malignancies (256), could facilitate the oxidation of AscH− to DHA and promote 
its uptake through upregulated GLUT transporters in melanoma cells (254). Studies 
have shown that genetic variations in SVCT-2 are associated with risk of certain cancers 
such as lypmhoma, human papillomavirus type 16-associated head and neck cancer and 
gastric cancer (257, 258). On the other hand, Lv and collegues investigated whether 
level of expression of SVCT-2 would play a role in selective cytotoxicity of P-Asc in 
cancer stem cells of hepatocellular carcinoma (259). The results suggested that SVCT-2 
expression was inversely associated with P-Asc concentrations needed to decrease 
hepatocellular carcinoma cells by 50%. Moreover, SVCT-2 expression was positively 
correlated with intracellular P-Asc concentrations and response to P-Asc. Wang et al.’s	  
study further showed that P-Asc treatment of knockdown of SVCT-2 in 
cholangiocarcinoma cells resulted in less DNA damage, ATP depletion and mammalian 
target of rapamycin (mTOR) inhibition (260). 
HIF-1 is a heterodimeric complex that plays an integral role in adaptive responses of the 
tumor cells to changes in O2 (261, 262). This involves not only a metabolic adaptation 
via channeling cells to a glycolytic pathway, but also transcriptional activation of 
various pro-angiogenic factors to increase O2 delivery (262). There is growing body of 
evidence, which suggests that AscH− by virtue of its role as a cofactor for HIF 
hydroxylases, may limit activation of HIF-1 (263). Two retrospective studies identified 
an inverse association between ascorbate levels in human endometrial (264) and 
colorectal tumor (265) tissues and the activation of HIF-1 pathway. Higher ascorbate 
content in tumor tissue was also associated with longer post-surgical disease free period 
(265). Another study demonstrated that in tumor-bearing Vitamin C dependent Gulo−/− 
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mice, increase in ascorbate intake alleviated levels of HIF-1α expression (266). On the 
other hand, in VHL-defective renal cancer cells, that already entail high levels of HIF-
1α activity, a higher uptake of DHA was observed through the HIF-1α upregulated 
GLUT-1 transporters (267). Given that these cells already rely on glycolysis through 
Warburg effect, P-Asc induced ROS generation and subsequent PARP activation led to 
NAD+ consumption and left very small amounts of NAD+ for glycolysis to proceed 
(267, 268). Consequently, significant reduction in cellular reserves of ATP promoted 
cell death (267). Whether P-Asc can selectively control tumor cell growth via inhibition 
of HIF-1 signaling or whether overexpression of HIF-1 serves, as an advantage for P-
Asc’s selective cytotoxicity towards tumor cells, seems to depend on the tumor type, 
concentration of administered P-Asc, amount of O2 available in the tumor 
microenvironment and the factors that influence the activation of HIF-1 (267). For 
instance, HIF-1α in VHL-defective renal cancer cells are constitutively stabilized and 
hypoxia or HIF prolyl hydroxylase activity has little influence on their activation (267, 
269). In such cases, inhibition of HIF via prolyl hydroxylase may not play a significant 
role in P-Asc’s anti-tumor activity. Vascular endothelial cell growth factor (VEGF) is a 
downstream gene product of HIF-1α and has been the focus of various targeted 
therapies (261, 270). Since HIF-1 activation could be potentially suppressed by P-Asc 
treatment, a possible concomitant decrease in VEGF was also investigated (264). 
Human endometrial tumor samples revealed a strong inverse correlation between level 
of VEGF protein and ascorbate content (264).  In a separate in vitro and in vivo study, 
P-Asc treated sarcoma 180 cancer cells had lower levels of VEGF and other two 
angiogenesis related proteins, but the authors did not elaborate on the mechanism of 
action (271). Wilkes and collegues noted that P-Asc treatment did reduce VEGF 
secretion which correlated with a decrease in HIF-1α expression but these effects were 
through a H2O2 mediated pathway rather than a O2 or prolyl hydroxylase-dependent 
inhibition of HIF-1α (272).  
Iron plays a critical role for proliferation and metabolism of cancer cells and infectious 
microorganisms such as bacteria and fungi (273, 274). These rapidly dividing cells are 
highly dependent on presence of iron to carry out various cellular processes such as 
DNA synthesis, cell cycle regulation and oxidative phosphorylation (274, 275). In order 
to meet the increased iron demands, many type of cancer cells upregulate proteins that 
are involved in its uptake. Transferrin receptor 1 (TfR1) is one of these proteins that 
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became the target of antibody-mediated chemotherapeutic agents (276). Iron chelators 
such as desferrioxamine and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone are 
also being considered as potential anti-cancer agents (277). On the other hand, iron’s 
ability to gain and lose electrons also enables it to participate in Haber-Weiss reaction, 
which leads to generation of free radicals. Therefore, in cells, which are rich in iron, a 
complementary strategy for anti-infective or anti-cancer therapy is to focus on agents 
that foster free radical generation. Cysteine, GSH and AscH− can slowly release iron 
from the iron storage protein ferritin (278). However, P-Asc by triggering an 
uncontrolled release of iron can generate a surplus, which in presence of O2, would lead 
to production of O2•−, HO• and H2O2 (229, 279, 280). ROS generated by P-Asc, can 
further increase the labile iron pool in part via H2O2 mediated disruption of iron-sulfur 
cluster proteins (280). This labile iron pool redox cycling can contribute to the P-Asc 
induced selective cytotoxicity.  
Schoenfeld and collegues reported that P-Asc treatment exerted preferential killing 
against of glioblastoma and advanced-stage-non-small-cell lung cancer cells in vitro and 
in vivo (280). In their study, GLUT mediated DHA uptake did not play a role in P-
Asc’s selective cytotoxicity but they argued that the effect was rather dependent on the 
increased redox-active labile iron present in cancer cells (280). Vilcheze et al. assessed 
the efficacy of P-Asc in treatment of Mycobacterium tuberculosis and their results also 
demonstrated that presence of high iron concentration played a critical role in its 
bactericidal effects (229). Kang et al. took a different view and proposed that P-Asc 
mediated death of melanoma cells were caused by P-Asc induced downregulation of 
TfR, which resulted in diminished iron uptake and subsequent apoptosis (281). 
P-Asc has been the subject of various studies, which assessed its antibacterial, 
antifungal and antiviral properties (229, 282). Its inhibitory effects on the growth of 
various microorganisms such as Staphylococcus aureus, Helicobacter pylori, 
Mycobacterium tuberculosis, Bacillus cereus, and Candida have already been 
demonstrated (229, 283-287). However, studies, which elucidate its mode of action are 
limited and, the specific conditions required for P-Asc to exert its anti-microbial effects 
seem to vary depending on the infectious agent. For instance, while P-Asc can inhibit 
Helicobacter pylori in microaerophilic conditions, similar concentrations of P-Asc were 
shown to increase survival under aerophilic conditions (286). On the contrary, P-Asc’s 
effect on Mycobacterium tuberculosis was abolished when the environment lacked O2 
DOI:10.14753/SE.2019.2290
26	  
	  
(229). Earlier studies suggested that the bactericidal effect of P-Asc was due to lowering 
of the pH (288, 289). In 1950, Slade and Knox challenged this hypothesis when they 
found a bacteriostatic effect for group A hemolytic streptococcus at near neutral pH 
(290). According to Ehrismann, while P-Asc stimulated growth in anaerobes, its effect 
was inhibitory in case of aerobes (288). In the process of exploring the role of O2 in 
bactericidal effects of P-Asc, Lwoff and Morel found that inhibition of Proteus vulgaris 
was halted by the presence of reducing agents and substances that catalyzed degradation 
of H2O2 (291). In 1954, Myrvik and Volk’s short-term growth experiments on Escheria 
coli (E. coli), was an attempt to reveal the chemical group that is responsible for the 
antibacterial properties of P-Asc. They reported that while enediol group of P-Asc had 
no antibacterial effect on E. coli, oxidized enediol (diketone) could exert immediate and 
strong antibacterial effects (284). Peloux and collegues proposed that P-Asc had little or 
no anti-viral activity in the absence of metal ions (282). Polio virus was completely 
inactivated when P-Asc was combined with 5 µM Cu2+ whereas, in the presence of 
ethylenediaminetetra-acetic acid (EDTA), P-Asc had no effect (282).   
Interestingly, presence of various microorganisms such as Acinetobacter baumanii and 
Candida albicans (C. albicans) induce human neutrophils to uptake DHA rapidly and 
recycle it to AscH−, such that AscH− concentrations of activated neutrophils in vitro 
could increase up to 30 fold above the concentrations present in resting neutrophils 
(292, 293). Whether accumulation of AscH− in such high amounts is an attempt of the 
phagoctytotic cells’ to enhance ROS generation or the cells want to take the advantage 
of its antioxidant properties while undergoing an oxidative burst is still an enigma (294-
297). 
Literature on P-Asc’s antifungal effects on C. albicans is contradicting. P-Asc was 
shown in vitro to reduce virulence of C. albicans cells by lowering proteinase secretion 
(285). The same study also demonstrated that P-Asc could arrest cell growth and, 
induce concentration dependent cytotoxicity, which was potentiated when the cells were 
treated with H2O2 (285). In a separate study by the same group, P-Asc induced 
oxidative stress related enzyme activities in C. albicans were examined and reduced 
levels of GSH, decreased enzyme activity of catalase, glutathione reductase, glutathione 
peroxidase and glutathione S-transferase were reported (298). These effects are similar 
to those observed upon continuous exposure of yeast cells to H2O2, where cells 
accumulated GSSG but the total amounts of GSH and GSSG were substantially 
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diminished, indicating inhibition of GSH synthesis (299). Surprisingly, some 
antioxidant effects were also demonstrated, such that with increasing concentrations of 
P-Asc, superoxide dismutase activity was increased and lipid peroxidation decreased 
(298). On the other hand, locally applied P-Asc in human subjects showed no antifungal 
activity against vaginal candidiasis or other antifungal infections (300). Only when P-
Asc was applied upon a successful	  treatment of fungal infection, it was able to prevent 
reinfection (300). Brajtburg and collegues suggested that P-Asc potentiates the lethal 
action of amphotericin B on C. albicans and Cryptococcus neoformans cells (301). 
Although in case of amphotericin B, P-Asc had such enhancing effects, P-Asc 
antagonized the effects of fluconazole both in vitro and in systemic murine candidiasis 
model (302). This inhibition was attributed to P-Asc’s reducing property which could 
diminish the oxidative effect of fluconazole induced ROS (302). Moreover, neither 
intragastrically nor intraperitoneally administered P-Asc had any effect on the survival 
of mice with systemic candidiasis (302). When Van Hauwenhuyse and colleagues 
further investigated the antagonistic effect of P-Asc on fluconazole, they found that only 
in the presence of Upc2 (a transcriptional regulator of Erg11 gene, which encodes an 
enzyme that is the target of azole antifungal drugs and is involved in ergosterol 
biosynthesis (303, 304)) P-Asc could exert its antagonistic effects (305). Their analysis 
also revealed that, P-Asc could restore the ergosterol levels and reverse elongated cell 
growth caused by inhibition or depletion of heat shock protein (Hsp90), and this activity 
was Upc2 dependent (305). Nevertheless, it is worth to mention that in normal cells, P-
Asc lowered ergosterol levels and did not initiate elongated growth (305, 306). 
In the 1970s, Ewan Cameron and colleagues conducted the initial clinical trials to test 
the effect of P-Asc on improving the survival of patients with terminal cancer (307-
309). Although their results were promising, subsequent double-blinded randomized 
studies in the Mayo Clinic demonstrated that orally administered P-Asc had no effect on 
patient survival (310, 311). It was later recognized that the route of administration might 
account for some of the discrepancy observed in, in vivo studies. Data suggested that 
intravenously administered P-Asc produced much higher plasma concentrations than the 
orally administered P-Asc due to the tightly controlled absorption process (64, 65, 312, 
313). For instance, when 10 g of P-Asc was delivered via infusion, it was possible to 
achieve plasma concentrations up to 5 mM, whereas predicted peak plasma 
concentration for P-Asc given at the maximum tolerable oral dose, 3 g every 4 hours, is 
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not more than 220 µM (65, 312, 313). It is also of importance to note that although 
several in vitro studies showed P-Asc to be highly effective as a single agent to 
selectively induce cell death in tumor cells and various microorganisms, many in vivo 
studies could achieve similar effects only when P-Asc was used as an adjuvant therapy 
and sometimes even as an adjuvant it indeed antagonized the effects of the 
chemotherapeutic agents due to drug-drug interactions (229, 285, 300, 302, 314-318). 
This discrepancy is presumably due to the inability of the in vitro conditions to 
precisely mimic the tissue environment with hypoxia and relevant metabolic changes. 
Moreover, tumor tissues are heterogenic and display distinct intra- and inter-tumoral 
variations in morphological and physiological features, such as diverse gene expression 
patterns, motility and metabolic profiles (319). The same heterogeneity and relevant 
cell-to-cell variation is also present in infections (320). A systemic review by Fritz and 
colleagues concluded that literature still lacks data from a well designed, controlled 
study with a large sample size, which suggests that P-Asc can be effectively used as a 
stand-alone cancer treatment (314). Nevertheless, results of current studies, mainly ones 
where P-Asc was used as an adjuvant therapy seem to be promising (314, 321, 322). An 
equally important finding of the authors from existing preliminary evidence is that P-
Asc is generally well tolerated and has a good safety profile (314). 
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1.3. Candida albicans  
C. albicans is a eukaryotic organism. As the member of a commensal microbiota, C. 
albicans can be isolated from the oral cavity, vaginal mucosa and gastrointestinal and 
urogenital tracts of most healthy individuals. However, as an opportunistic pathogen it 
is also the most common cause of fungal infections (323-327). Although majority of 
infections are confined superficially to the mucosa, skin and nails, treatment can still be 
challenging (328-330). Moreover, in immunocompromised patients, invasive 
candidiasis (eg. candidemia or deep-seated infections) generally caused by direct 
inoculation to a sterile site, dissemination through blood, or less frequently as a result of 
ascending pyelonephritis, can lead to significant morbidity and mortality (325, 331).  
1.3.1. Physiological, morphological and metabolic profile 
One of the distinct features of C. albicans is its ability to grow in a number of different 
morphological forms such as yeast, pseudohyphae and true hyphae (332, 333). 
Unicellular yeast cells (blastospore, blastoconidium) generally have a round or oval 
shape and they divide through budding. Pseudohyphae and hyphae are the two 
filamentous forms that occur in response to alterations in the environmental conditions 
such as changes in temperature, pH or nutritional sources (333, 334). Hypha originates 
from a single elongated yeast cell termed as germ tube, which grows by apical extension 
and differentiates into tubular structures that are separated by septa (333, 334).  
Pseudohyphae are intermediate between the yeast and hyphae forms. In case of 
pseudohypha, daughter bud elongates but does not separate from the mother cell (333, 
334). One of the distinct features that distinguish pseudohyphae from hyphae is the 
presence of constrictions at the septal junctions. In hyphae such constrictions do not 
exist and walls lie in parallel throughout the entire structure (333, 334).  
Most microorganisms including yeasts grow in three main phases; lag phase, 
exponential (log) phase and stationary phase. Duration of each phase depends on 
various conditions such as temperature, pH, O2 level and availability of nutrients (335). 
Lag phase is the adaptation and preparation phase (335, 336). During this period, cells 
are metabolically active (337-339). They start to upregulate relevant genes and 
synthesize the enzymes needed for cell division (335). At this stage number of cells 
remains relatively constant (335). Once they enter the exponential growth phase, their 
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number increases rapidly and the cells reach their peak metabolic activity (335). In 
general, this continues until they exhaust the available nutrients and accumulate 
metabolic end products (340-342). In stationary phase, there is a dramatic decrease in 
overall growth rate and cells try to maintain their viability by going through a variety of 
biochemical and morphological changes (335, 341-343). For instance, Uppuluri and 
Chaffin demonstrated that during stationary phase (which they defined as cells cultured 
for a minimum for 5 days), C. albicans showed increased expression of genes that are 
involved in processes such as cell wall biosynthesis, adherence, DNA repair and stress 
resistance (341). While majority of the genes involved in glycolysis pathway, and 
glucose transport were highly expressed in the exponential phase, such high expression 
was not observed in the cells that were in the stationary phase (341). However, the exact 
timeline regarding when yeast cells including C. albicans enter stationary phase and 
whether it is indeed considered as a distinct phase of growth still varies from one study 
to another (298, 341, 343-349). These variations may also account for some of the 
contradicting results regarding the biochemical changes that occur in stationary phase. 
C. albicans can efficiently adapt to a wide range of environmental conditions, by a rapid 
metabolic switch, which is usually accompanied by a phenotypic switch (341, 343, 349, 
350). This turns metabolism of C. albicans into a highly complicated process. C. 
albicans contains both conventional and alternative respiratory pathways and their level 
of expression alternate depending on the growth conditions (351, 352). In mammals, 
NADH-ubiquinone oxidoreductase (Complex I), cytochrome bc1 (Complex III) and 
cytochrome oxidase (Complex IV) are the proton translocating oxoreductases in the 
respiratory chain (353). On the other hand, besides Complex I, C. albicans also contains 
other forms of NADH-oxidoreductases (351, 352, 354). They catalyze rotenone 
(inhibitor of Complex I) insensitive oxidation of matrix NADH or enable direct use of 
cytoplasmic NADH (351, 352). In addition, C. albicans can also express an alternative 
cyanide (inhibitor of Complex IV) and antimycin A (inhibitor of Complex III) 
insensitive oxidase, which is reduced directly by the electrons of the ubiquinol pool 
(351, 352, 355-357). Both oxidative stress and, respiratory chain inhibitors acting 
downstream from coenzyme Q was shown to induce anternative oxidase, which 
suggests that it supposedly protects fungi from oxidative damage (351, 358, 359).  It 
may also be possible that alternative oxidase enables ATP synthesis to continue when 
the conventional pathway is inhibited (352).  
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C. albicans grows best under aerobic conditions, but studies suggested that it can also 
exhibit a limited degree of anaerobic growth (360, 361). This is important for C. 
albicans infections and especially biofilms that colonize tissues, foreign bodies, 
prosthetic devices and tissues in regions with insufficient amounts of O2 like for 
example gastrointestinal tract and wounds covered with dressings. Studies regarding the 
respiratory activity of C. albicans in relation to its growth and morphology are still 
contradicting (345, 356, 362). Aoki and Ito-Kuwa’s observed that cells increased their 
O2 uptake during lag phase and initial stage of log phase (337). Ogasawara et al. 
reported that C. albicans cells in lag phase do not use O2 and instead they generate ATP 
via fermentative metabolism whereas cells in exponential phase do use O2 and utilize 
oxidative phosphorylation (339). They have further suggested that the cells employed 
glycolysis pathway to generate energy required for proliferation only in anaerobic 
conditions (339). On the other hand, Uppuluri and Chaffin’s study indicated that C. 
albicans prefers aerobic respiration during exponential growth but they have also 
demonstrated that expression of genes involved in glycolysis pathway and glucose 
transport were increased during the same period (341). Land et al. documented that 
hyphal growth is associated with suppression of mitochondrial activity, diminished O2 
consumption and reduced activity of tricarboxylic acid (TCA) cycle enzymes (362). 
Majority of mature ‘hard to treat’ biofilms contain 95% hyphae and interiors of biofilms 
in general have very limited access to O2 (363, 364). The commonly encountered 
difficulty in treating biofilms may be in part explained by the study conducted by 
Dumitru et al. in which the authors showed that anaerobically grown cells exhibited 
minimum fourfold more resistance to antifungals like miconazole, fluconazole, 
amphotericin B and terbinafine compared to the aerobically grown ones (360).  
As mentioned above, C. albicans inhabits in diverse niches from the oral cavity and 
urogenital tract to the bloodstream and internal organs and only few of these niches are 
rich in glucose, the preferred carbon source for C. albicans (365-367). However, most 
tissues have sufficient supply of alternative carbon sources, such as lactate, fatty acids, 
and amino acids. C. albicans possesses the ability to assimilate these less favorable 
alternative carbon sources when the environment lacks glucose or possibly even for 
some time after glucose becomes available (368). At the same time, according to 
Rodaki and colleagues, C. albicans is highly sensitive to glucose, such that upon 
exposure to glucose at concentrations as low as 0.01%, glycolytic genes were shown to 
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be up-regulated, and gluconeogenic, glyoxylate cycle, TCA cycle and fatty acid β-
oxidation genes were shown to be down-regulated (369). Conversely, when glucose is 
depleted, expression of genes that are involved in β-oxidation were shown to be 
elevated (341). Nevertheless, Uppuluri and Chaffin also showed that even at high 
glucose levels, C. albicans never completely shuts down its respiratory metabolism and 
indeed mitochondrial respiration is the preferred pathway in all growth phases (341). 
Glucose also plays a crucial role in response of C. albicans to oxidative stress. For 
example, it significantly increases the resistance of C. albicans to high doses of H2O2 
(>10 mM) (369). This phenomenon may justify the increased risk of Candida infections 
observed in diabetic patients or enhanced colonization and invasion in tissues that are 
rich in glucose (370, 371). Similarly, it may also explain the increased resistance of 
glucose treated cells to an azole antifungal drug, miconazole (369).  
Lastly, C. albicans cells’ response to new environmental conditions differs depending 
on various factors such as the growth phase, presence or absence of certain quorum 
sensing molecules and/or the amount of time spent in the previous growth conditions 
(345). For instance, when cells were grown overnight at 37°C to stationary phase and 
then diluted into fresh culture medium under the same conditions, this change in the 
growth environment triggered a transient but substantial induction of hyphae formation 
(345). However it must be noted that, in the described experimental setting, while the 
cells grown to exponential phase had no capacity to form hyphae, the number of hyphae 
generated 3 h after the dilution increased as the cells approached to stationary phase 
(345). Moreover, H2O2 sensitivity of C. albicans was shown to be growth phase 
dependent, such that incubation of cells with H2O2 for 60 min in fresh minimal media 
resulted in a dramatic reduction in viability of early exponential phase yeast cells 
whereas stationary phase cells were highly resistant to H2O2 exposure (15% survival in 
early exponential phase cells vs 112% survival in stationary phase cells) (349). 
Furthermore, when early-exponential-phase cells were resuspended in fresh medium or 
conditioned medium (supernatant obtained from the overnight stationary phase culture) 
for 90 min and then exposed to H2O2 in minimal fresh media, percentage of cells that 
survived in pretreated conditioned medium were significantly higher than those 
pretreated in fresh media (101% vs 11% respectively) (349). Authors of this study 
suggested that farnesol, a quorum-sensing molecule excreted into the medium was 
partly responsible for the oxidative resistance generated by the conditioned medium, 
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and the conditioned medium induced transcription of antioxidant-encoding genes might 
have played a role in protection of cells against oxidative stress (349).  
As discussed in earlier chapters, when organisms perform aerobic respiration, ROS is 
generated and various antioxidation mechanisms are employed for protection against 
possible oxidative damage. For fungal pathogens, interaction with the phagocytic cells 
in particular, causes them to encounter extreme levels of oxidative stress (372). In order 
to thrive in such environments, fungi utilize various enzymatic and non-enzymatic 
mechanisms that include catalase, superoxide dismutase and GSH (299, 372). Although, 
some studies suggest that ascorbic acid in yeast cells is absent (373-375), several studies 
also show that they can synthesize D-erythroascorbic acid, a five-carbon analogue, 
which possesses chemical properties, very similar to those of ascorbic acid (376, 377). 
Studies confirming D-erythroascorbic acid’s role as an antioxidant do exist, but whether 
it has a significant role in protecting cells from stress is still under debate (376, 378, 
379). Of note is that, when Branduardi and colleagues constructed recombinant 
Saccharomyces cerevisiae (S. cerevisiae) cells, producing endogenous L-ascorbic acid, 
they observed increased resistance to oxidative stress (373). Likeweise, S. cerevisiae 
cells exposed to L-ascorbic acid at 10 mM exhibited higher tolerance against heath 
shock and lower levels of ROS accumulation (380). 
1.3.2. Treatment 
There are five main classes of antifungal agents; polyenes, azoles, allylamines, 
nucleoside analogues and echinocandins. Azoles such as ketoconazole, fluconazole and 
itraconazole inhibit the enzyme 14α-lanosterol demethylase and consequently block 
biosynthesis of ergosterol - the sterol component of the cell membrane (381). 
Amphotericin B, which belongs to the group of polyenes binds irreversibly to 
ergosterol, forms pores that cause leakage of intracellular ions and lead to subsequent 
cell death (382). The allylamine terbinafine exerts its antifungal effects by inhibiting 
squalene epoxidase (383). Flucytosine is a nucleoside analog and impairs fungal DNA 
and ribonucleic acid (RNA) synthesis (384). Echinocandins are a relatively new class of 
antifungal agents and they inhibit beta-1,3-glucan-synthase, an essential component of 
the fungal cell wall (385). Studies suggest that under specific conditions some of these 
antifungals may also induce generation of ROS (381, 386). Despite the availability of 
numerous antifungal agents with broad and narrow activity spectra; emerging antifungal 
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resistance, detected and anticipated side effects and host toxicity, partly due to extensive 
similarities between fungal and human cells, require and pinpoint the development of 
new therapeutic strategies (387-391).  
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1.4. Basal Cell Carcinoma 
Basal cell carcinoma (BCC) is a keratinocyte-derived neoplasm of the skin (392). It is 
the most common type of cancer among Caucasians and its incidence is on the rise 
(393-395). There is considerable phenotypic diversity among patients in terms of 
number of lesions they develop, anatomic locations of these lesions and the patterns of 
presentation. For example, BCC usually occurs on sun exposed body sites such as the 
head and trunk but lesions on non-sun exposed areas like the axilla, nipple and genital 
area have also been reported (396-398). Genetic and environmental factors both play a 
role on predisposition to BCC. The most significant risk factor is believed to be 
exposure to solar UVB radiation, which ranges from 280 to 315 nm (399). UVB induces 
formation of strand breaks and formation of covalent bonds between adjacent 
pyrimidine bases that leads to generation of cyclodipyrimidine dimers (T/T) and (6-4) 
pyrimidine-pyrimidone photoadducts in the DNA (121, 399-401). When left unrepaired 
these photoproducts can cause mutations, which can in turn result in abnormal cell 
growth. Especially, the mutations that activate the Hedgehog signaling pathway genes, 
such as patched (PTCH), Sonic hedgehog (Shh) and Smoothened (Smo) play an 
important role in development of BCC lesions (399, 402-406). Other important risk 
factors include, UV exposure, drug induced immunosuppression, arsenic exposure, fair 
skin color and advanced age (407-415).   
BCC generally presents as a slow growing, translucent or pearly, papule or nodule with 
telangiectasias and a central ulceration. It has various subtypes, based on clinical 
presentation, growth pattern and histology (416-419). Clinical subtypes include nodular, 
ulcerative, superficial, pigmented and morpheiform BCC and fibroepithelioma of 
Pinkus (416, 417). A separate classification system identifies histological subtypes, 
which include but are not limited to nodular, micronodular, superficial, infiltrating, 
morpheiform and fibroepithelial BCC (417, 420). Growth pattern assists identification 
of aggressive and high-risk subtypes with potential tumor recurrence and based on 
growth pattern BCC is further classified as nodular, superficial, infiltrating, 
morpheiform, micronodular and basosquamous (417, 421). Among these, nodular and 
superficial are considered as less aggressive and low risk subtypes. However, it must be 
noted that to date there is no universally agreed classification and variations exist in 
definition and terminology (418, 421, 422). 
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BCC occurs sporadically, with some exceptions such as basal-cell nevus syndrome 
(BCNS, Gorlin syndrome, nevoid basal-cell carcinoma syndrome) - a rare autosomal 
dominant disorder in which patients inherit a germline mutation in the tumor suppressor 
gene PTCH (423, 424). Most common features of BCNS include multiple lesions of 
BCC, palmar and plantar pits, central nervous system abnormalities such as calcification 
of falx cerebri, skeletal defects and benign odontogenic keratocysts of the jaw (423). 
However, multiple lesions of BCC are not unique to BCNS. For example, in case of 
hereditary nonsyndromic multiple BCC, skin lesions exist without any associated 
anomalies (425). Although rare, some cases of multiple BCC also exist without any 
associated anomalies and any family history (426-428). 
Common methods used in the treatment of BCC include surgical excision, cryosurgery, 
electrodessication and curettage, radiotherapy, photodynamic therapy, 5-fluorouracil, 
imiquimod and mohs surgery (429-431). Although most lesions are indolent and 
respond well to local treatments, some can occasionally progress to an advanced state 
where they may no longer be suitable for local therapy (431, 432). Moreover, for 
patients who have multiple BCC, traditional treatment modalities may be impractical, 
contraindicated, not effective and sometimes grossly disfiguring (428, 430, 433). 
Vismodegib (Erivedge; Roche) and sonidegib (Odomzo; Novartis), the two small 
molecule antagonists that target the Hedgehog signaling pathway by binding to and 
inhibiting Smo, are considered as the therapeutic options for such cases (430, 434, 435). 
Nevertheless, while using these medications, patients might experience adverse events, 
which sometimes lead to noncompliance and discontinuation of therapy (435, 436). 
Moreover, there are cases where patients do not completely or even partially respond or 
resistance develops	  (428, 437, 438). Therefore, the development of new BCC therapies 
is an active field of investigation. 
It has been postulated that activation of Hedgehog signaling pathway is associated with 
altered energy metabolism (439, 440). In 2012, Chen and colleagues explored the role 
of Hedgehog signaling pathway in induction of a metabolic switch to glycolysis, which 
could in turn result in lactate accumulation, and inhibition of adipogenesis, in quiescent 
hepatic stellate cells that transform into myofibroblasts (439). Their findings 
demonstrated that Hedgehog signaling was indeed necessary for increased expression of 
genes that regulate glycolysis and, Smo upregulated HIF-1α expression was involved in 
this process (439). Recently, Seleit et al. demonstrated for the first time that nodular 
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type BCC lesions in humans showed higher HIF-1α expression percentage when 
compared to the normal dermis (441). Teperino and colleagues further illustrated that 
activation of Smo could initiate a Warburg-like metabolic reprogramming by 
modulating proteins such as adenosine monophosphate (AMP)-activated protein kinase, 
pyruvate kinase M1/M2 and pyruvate dehydrogenase α-1, some of which also play a 
role in stimulation of GLUT-4 dependent glucose uptake (440).  On the other hand, 
literature regarding GLUT expression in BCC is contradicting. Abdo et al. detected 
GLUT-1 expression in 62.5% of nodular and adenoid type BCC cases (n=16), and the 
expression was more likely to be localized at the center of the malignant basaloid nests 
(442). This type of localization may be associated with presence of hypoxia which is 
more common in areas that are not in close proximity to blood vessels (443). However, 
when the same authors investigated the GLUT-1 expression in cutaneous squamous cell 
carcinoma (SCC), they found that GLUT-1 was expressed in all SCC lesions (n=16) and 
this expression was related to differentiation status, such that high percentage of GLUT-
1 expression was usually associated with poorly differentiated SCC (442). In a 
subsequent study performed with 20 nodulo-ulcerative type BCC lesions, GLUT-1 
expression was found to be downregulated in comparison to normal skin (441). When 
histological subtypes were analyzed in terms of localization, in a nodular type BCC 
lesion, GLUT-1 expression was mainly confined to the center of the lesion, whereas in a 
keratotic type BCC lesion, GLUT-1 was expressed mostly around the areas of keratotic 
differentiation (441). On the other hand, Baer et al. found no GLUT-1 expression in any 
of the BCC lesions, and the expression was also absent in areas with focal squamous 
metaplasia and keratinization (444). Intriguingly, same study also showed that almost 
all cases of SCC had moderate to intense levels of GLUT-1 expression (444). In 
addition, in case of invasive SCC, GLUT-1 expression was more prominent in 
infiltrative and/or less differentiated regions (444). Positron emission tomography 
(PET) is a commonly used modality in oncology and it detects the tumor cell uptake of 
the radiolabeled form of glucose so called 2-deoxy-2-[18F]fluoro-D-glucose (FDG). 
This modality relies on the higher rate of glycolysis commonly observed in the tumor 
tissue which results in a higher uptake of FDG (445). A positive correlation between 
FDG uptake and GLUT-1 expression have already been demonstrated in various types 
of lung cancers (446). Therefore, PET imaging of BCC lesions may further elucidate the 
GLUT-1 expression in BCC cells. For example, a case series of 6 patients with 4 
nodular and 2 invasive BCC lesions demonstrated that 3 of the 4 nodular lesions were 
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PET-positive while all invasive lesions were found to be PET-negative (447). The 
authors argued that although negative results could be due to the differences in tumor 
metabolism among histological subtypes, various factors such as small tumor size or 
low blood flow could have also affected the sensitivity (447). On the other hand, Ali 
and colleagues were able to successfully image a small BCC lesion, which 
demonstrated focal nodulocystic growth and partly basosquamous differentiation (448). 
Therefore, they suggested that rather than lesion size, it was probably GLUT-1 
expression or other factors involved in variations in PET images of BCC (448). A third 
case report by Beer and Waibel also documented the detection of a large recurrent BCC 
by a PET scan (449). Likewise, an intense FDG uptake was observed in a primary BCC 
lesion with nodular and infiltrative patterns and this was accompanied by 
hypermetabolic lymph nodes, suggestive of metastatic BCC (450). Thacker and 
colleagues utilized PET to assess the treatment response of advanced and metastatic 
BCC to vismodegib by monitoring the changes in metabolic activity (451). Authors 
concluded that metabolic activity decreased in all lesions following therapy although the 
degree of reduction varied among lesions. As demonstrated by Evans et al. in 2006, O2 
levels in human skin are not uniformly distributed, such that while dermis is well 
oxygenated, epidermis is mildly hypoxic and the regions where sebaceous glands and 
hair follicles are located are in part severely hypoxic (452). Consistent with these 
findings, high levels of HIF-1α were detected particularly in the basal layer of the 
epidermis of human skin (453-456). Considering that in both healthy skin and certain 
types of skin cancers, regions of hypoxia and HIF-1α expression generally coincides 
with regions of GLUT-1 expression, HIF-1α and GLUT-1 in BCC lesions are expected 
to be disproportionally expressed both intratumorally and among different subtypes 
(443, 453, 457). As BCC lesions are mostly indolent and GLUT 1 expression was 
shown to be much higher in ‘’stem-like’’ basal cells in comparison to differentiated 
keratinocytes, one may also expect variations in expressions among invasive and non-
invasive subtypes (457).  
Tumor angiogenesis, which is generally associated with microvessel density and VEGF 
expression, is considered as an important step in acquisition of an aggressive phenotype 
and metastasis (458-464). Stabiano et al. demonstrated that angiogenic rates were much 
higher in infiltrating and metastasizing BCC lesions than those in non-aggressive 
subtypes (463). Consistent with these findings, Loggini and colleagues showed that 
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mean vascular density was higher in sclerosing subtype – an aggressive form of BCC, 
than in the nodular and superficial subtypes which are considered to be indolent forms 
of BCC (461). Likewise, a separate group revealed that both VEGF expression and 
mean vascular density were higher in morpheaform and, nodular lesions with a deep 
dermal involvement, than those in superficial BCC lesions (459). However, the 
expression of VEGF, peritumoral and intratumoral blood vessel areas and their counts, 
and the mean vascular density in BCC do not seem to be as high as those in SCC (460, 
461, 463, 465, 466). Moreover, some studies did not even find any VEGF expression or 
increase in capillaries, in certain BCC lesions (461, 467, 468). This may be attributed to 
variations in growth pattern and metabolism in different BCC subtypes (461).  
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1.5. Two-Photon Excitation Fluorescence Microscopy  
Fluorophore is a molecule that can fluoresce by absorbing energy of a particular 
wavelength light (photon) and subsequently emitting light of a longer wavelength than 
what was initially absorbed (469, 470). When the electron in the ground state absorbs 
energy from an incoming photon, it may rise to a higher energy state, so called the 
‘’excited state’’. While the electron goes back to its ground state, several processes 
occur with varying probabilities, but generally the energy that was initially absorbed is 
partly dissipated as heat and mainly emitted in the form of fluorescence radiation (469). 
One-photon fluorescence process utilizes only a single photon that is usually in the UV 
or blue/green spectral range, to excite a fluorophore from the electronic ground state to 
an excited state (471, 472). On the other hand, in two-photon excitation fluorescence 
microscopy (TPEFM), the molecule is excited by the simultaneous absorption of two-
photons, which are usually in the red or near infrared spectral range (473, 474). Hence, 
each of these photons carries almost half the energy that is needed to excite the 
molecule via a one-photon process. As the likelihood of simultaneous absorption of 2 
photons is extremely low, a high photon flux needs to be delivered to the sample. This 
is commonly achieved by tightly focused, high repetition rate (100 MHz), ultrafast 
(femtosecond or picosecond pulse widths) lasers, such as titanium–sapphire or 
neodymium-doped yttrium lithium fluoride (Nd:YLF) lasers (473, 474). Consequently, 
the fluorophore excitation and thus the emission gets restricted to the area near the focal 
plane where the photon density is highest (474). Unlike UV or blue-green light, 
excitation wavelengths used in TPEFM scatter less and the molecules that are 
abundantly found in tissues and cells generally do not absorb these wavelengths. These 
properties enable deep tissue penetration, minimize photobleaching and phototodamage 
and, reduce signal loss by eliminating the need for a pinhole aperture (473, 474). Of 
note, the pinhole aperture is commonly employed in single photon microscopes in order 
to reject the out-of-focus fluorescence that is indistinguishable from the scattered light 
emitted from the excited fluorophore. These advantages turn TPEFM into a suitable tool 
for real time lable free imaging of deep tissues and live cells to assess cellular and 
subcellular events.   
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1.5.1. Monitoring intracellular redox status by conventional confocal and 
two-photon excitation fluorescence microscopy 
One of the applications of TPEFM is label free monitoring of cellular metabolic activity 
and redox status in living cells, by evaluating intracellular levels of the endogenous 
fluorophore, NAD(P)H (475-478). While NADH is mainly generated by glycolysis and 
TCA cycle and consumed by electron transport chain, anaerobic glycolysis or 
fermentation; its phosphorylated analogue NADPH is involved in anabolic reactions 
such as lipid, amino acid and nucleotide biosynthesis (479). NADPH also has an 
important role in detoxification and antioxidant defense, for example it is required for 
reduction of GSSG and subsequent generation of GSH (169, 479-481). Both NADH and 
NADPH absorb light and emit fluorescence at 340±30 nm and 460±50 nm, respectively, 
but their oxidized forms NAD+ and NADP+ are not fluorescent (482-484). While 
NAD(P)H has a relatively low quantum yield (ratio of emitted photons to the number 
absorbed) and the fluorescence signal acquired by conventional one photon imaging is 
usually weak, TPEFM can provide the energy that is required for its transition from 
ground state to the excited state (168, 485, 486). TPEFM can also reduce the potential 
photodamage and photobleaching that generally stems from its excitation peak, which 
falls in the UV range.  
In most cells, NAD+ levels are much higher than those of NADP+, however the 
difference in intracellular concentrations of NADH and NADPH is generally less (166, 
168, 487). One reason is that NADH/NAD+ ratio is usually kept low due to NAD+’s role 
as an electron acceptor in catabolic pathways (166, 168, 488). Moreover, in case of 
hypoxia or oncogenic metabolic transformations where Warburg effect is proposed to 
take place, in order to keep gycolysis active, cells may restore the NAD+ pool through 
regeneration of NAD+ from NADH by the enzyme lactate dehydrogenase, which 
facilitates the conversion of pyruvate to lactate (168, 240, 489).  On the other hand, in 
anabolic pathways and antioxidant defense, the primary role of NADPH is as an 
electron donor and hence the NADPH/NADP+ ratio needs to be kept at relatively high 
levels (166, 168, 490). In most cells, NADPH is produced and maintained at such high 
levels mainly through the actions of the two enzymes of the pentose phosphate pathway; 
glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase (491). 
Nevertheless, there is an intriguing interplay between NAD(H) and NADP(H) that is 
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particularly pronounced in response to new conditions such as aeration, oxidative stress 
and UV irradiation. Multiple enzymes have been shown to take part in this interplay and 
they directly or indirectly regulate the balance between the two (479, 487, 492-494). For 
example, nicotinamide nucleotide transhydrogenase (NNT), can catalyze the reduction 
of NADP+ at the expense of NADH oxidation and H+ reentry to the mitochondrial 
matrix (487). NADH kinase is another enzyme, which is shown to transfer a phosphate 
group from ATP to NADH to generate NADPH (495). Recently Singh and colleagues 
also demonstrated that under conditions of oxidative stress, Pseudomonas fluorescens 
utilized the enzyme NAD kinase to orchestrate the production of NADP+ at the expense 
of NAD+ (494). A concomitant increase in NADP+ in turn promoted the production of 
NADPH, and enhanced the cell’s antioxidant activity. In addition, reduction of the 
available NAD+ pool diminished synthesis of NADH, hence limited the potential 
generation of ROS from its downstream metabolism mediated by complexes I, III, and 
IV during electron transport chain (494, 496). In a separate study, when ROS generation 
was induced by menadione, a concomitant decrease of NAD(P)H autofluorescence was 
recorded (497). Likewise, when C. albicans cells were treated with garlic extract, 
containing endogenous dialliyl disulphide, increased level of ROS was observed (498). 
This increase was paralleled by a decreased mitochondrial membrane potential, GSH 
and attenuated cytoplasmic and mitochondrial NAD(P)H signals detected by TPEFM 
(498). Taken together, at each pixel of an image, the change in the intensity of 
NAD(P)H fluorescence might provide insights into the changes in the 
NAD(P)H/NAD(P)+ ratio and reflect the balance of oxidation and  reduction reactions at 
that region (168). However, it must also be noted that some groups consider the cellular 
level of NADH to be greater than NADPH and interprete the change in NAD(P)H 
signal as an alteration of NADH only (484, 499-503). This leads to inconsistencies 
regarding the interpretation of the signals collected from NADH and NADPH. 
In general, flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) serve 
as cofactors for enzymes that participate in oxidation-reduction reactions (504). For 
instance, during the electron transport chain, similar to NADH, reduced form of FAD 
(FADH2) transfers its hydrogen atoms to O2 to drive the synthesis of ATP. Research has 
demonstrated that endogenous fluorescence signal intensity of FAD can provide further 
input to better understand the metabolic redox state of the mitochondria (475-477, 484, 
505, 506). As only FAD and NAD(P)H are sufficiently fluorescent, and as their redox 
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states are generally in equilibrium within the mitochondria, signals from these two tend 
to respond oppositely to changes in mitochondrial metabolic activity and redox state 
(475, 476, 507). For instance, in breast cancer cells treated with rotenone, an inhibitor of 
Complex I, a reduced cellular redox state was confirmed by an increased NADH 
fluorescence, decreased FAD fluorescence and a decreased FAD/NADH ratio (506). On 
the other hand, Armstrong et al. demonstrated that upon exposure to various 
concentrations of H2O2, a concentration dependent decrease in NADH and an increase 
in FAD autofluorescence occurred in vitro (508). Kuznetsov and colleagues’ study 
further revealed that doxorubicin treatment of breast cancer cells induced ROS and, 
resulted in a rapid increase in flavoprotein signal, which was accompanied by a 
remarkable decrease in NADH autofluorescence in the mitochondria (476). These 
findins paralleled with reduced membrane potential (476).  
Current imaging techniques that utilize TPEFM for imaging of FAD, also have their 
drawbacks such as difficulty in completely separating the overlapping NAD(P)H and 
flavoprotein signals, and low quantum efficiency in detecting flavoprotein 
autofluorescence (475). Therefore, some studies prefer quasi-simultaneous imaging of 
flavoproteins by conventional confocal microscopy and, NAD(P)H by TPEFM, over 
simultaneous imaging of the two via TPEFM (507). Moreover, discrepancies related to 
alterations in redox potential caused by variations in tumor microenvironment, patient’s 
age, substrate availability, tissue processing, imaging parameters and set ups or methods 
used for quantitative analysis of redox ratios do also exist (501, 509-511). Taken 
together, detection and monitoring of NAD(P)H and FAD autofluorescence via 
conventional confocal and TPEFM imaging may have potential future implications for 
mechanistic studies, diagnostics as well as for monitoring treatment response (501). 
However, further studies are needed for standardization purposes and further 
improvement of these techniques.  
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1.6. Second Harmonic Generation Microscopy 
Second harmonic generation microscopy (SHG) is based on two photons interacting 
simultaneously with a target molecule to emit a new photon with twice the energy, 
however unlike TPEFM, in which two photons are simultaneously absorbed to produce 
a single photon of fluorescent emission, SHG specifically involves scattering of photons 
and the target molecule is non-centrosymmetric (501, 512-514). In biological tissue, 
structures such as type I and II collagen fibers, microtubules and myosin can produce 
SHG signals endogenously without the addition of exogenous probes (515-517). 
Because SHG is a coherent process, the amount, direction, and polarization of emission 
is not only dependent on the concentration of the scatterers, but it also depends on their 
spacing, order and orientation (501). This property enables imaging of various fine 
details of the tissue structure that is not visible by other modalities.  
Literature suggests that the cross talk between tumor and tumor stroma has a strong 
influence on behavior of cancer cells (518-521). Along these lines, many of the in vivo 
studies utilizing SHG aim to elucidate the role of peritumoral collagen in detection of 
tumor genesis and prediction of tumor progression (522-525). For instance, Conklin et 
al. demonstrated that perpendicular alignment of straightened collagen fibers to the 
tumor boundary was suggestive of decreased survival in human breast cancer (526). 
However, it must also be noted that collagen alterations differ according to the tumor 
type, stage and grade (525, 527). A study on ovarian cancer found an association 
between malignant tissue and dense and highly ordered collagen fibers (528) and when 
Chen and colleagues compared normal vs cancerous gastric tissues, they observed 
diminished collagen area in the latter group (529). Moreover, according to Drifka et al. 
increased collagen width, length, straightness and alignment, especially around 
malignant ducts, were stromal characteristics of pancreatic ductal adenocarcinoma 
(530).  
In case of skin cancer, studies are yet limited. Lin et al. detected lower SHG signals 
obtained from collagen in BCC stroma than those obtained from collagen in normal 
reticular dermis (531). Two other groups described that in BCC, basaloid nests are 
tightly surrounded by parallel fibers (532, 533) but in healthy skin straight fibers are 
oriented along different directions (533). Recently, Kiss and colleagues further 
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demonstrated that in comparison to healthy skin samples, BCC lesions exert increased 
collagen fiber length and alignment but similar collagen width and straightness (534). 
One major concern in evaluation of tumor stroma by SHG is the stability of collagen 
features under various tissue-processing procedures (eg. frozen samples in embedding 
medium, frozen samples that have not been embedded, and formalin-fixed paraffin-
embedded tissue). Various reports suggest that collagen features and fluorescence 
properties are stable and well maintained in all these conditions (525, 526, 535). 
Nevertheless, further work is still needed to clarify any possible effect of tissue 
processing procedures. 
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2. Objectives 
Literature regarding P-Asc’s prooxidant effects on tumor cells and infectious agents is 
still controversial and, rather scarce for the latter. This controversy stems from various 
reasons including but not limited to, differences between in vitro and in vivo conditions, 
tissue heterogeneity and AscH−’s tendency to interfere with reagents used in chemical 
assays.  Moreover, its exact mechanism of action is yet to be further explored. In an 
attempt to clarify some of these problems, we aimed: 
 
1/a. To define specific metabolic and environmental conditions under which P-Asc 
exerts cytotoxic effects on C. albicans cells 
1/b. To investigate production of HO• formation and, indirectly the involvement of 
Fenton reaction in prooxidant effects of P-Asc on C. albicans cells 
1/c. To utilize lable free single live cell fluorescence imaging techniques to monitor 
intracellular redox status of P-Asc treated cells and real time treatment response 
1/d. To investigate morphologic and organ specific alterations at the single cell level 
by utilization of lable free optical imaging tools  
2. To exploit lable free single live cell fluorescence imaging techniques to assess 
fine changes of tissue pathology during intravenous P-Asc (IVA) therapy that 
may not be apparent in standard hematoxylin and eosin stained histology 
sections.  
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3. Materials and methods 
3.1. In vitro studies on Candida albicans 
3.1.1. Materials 
All chemicals used for the experiments were purchased from Sigma-Aldrich (MO, 
USA) unless otherwise stated. L-ascorbic acid was dissolved in phosphate-buffered 
saline (PBS) (free of Ca2+/Mg2+), PBS with D-(+)-glucose (20 g/l), YPD medium (yeast 
extract 10 g/l; peptone 20 g/l; dextrose 20 g/l, [BD-DifcoTM, NJ, USA]) or YPG 
medium (yeast extract 10 g/l; peptone 20 g/l [ForMedium Ltd., Norfolk, UK]; glycerol 
38 g/l). Stock solutions of P-Asc were prepared on the same day of experiment and pH 
was adjusted to ≅ 7 with NaHCO3 (Fisher Scientific, PA, USA). The final concentration 
of P-Asc was 90 mM in all experiments. Final concentrations of 2,2′-bipyridyl dissolved 
in dimethylacetamide and 2-[6-(4'-hydroxy)phenoxy-3H-xanthen-3-on-9-yl]benzoic 
acid [(3′-(p-Hydroxyphenyl)-fluorescein, HPF; Molecular Probes, OR, USA)] were 500 
µM and 5 µM, respectively.  
3.1.2. Cell culture 
The C. albicans strain CEC 749 was used in this study (536). C. albicans was grown at 
30°C on YPD agar and subcultured in liquid YPD medium in a rotary shaker incubator 
at rpm 120 (New Brunswick Scientific, NJ, USA), at 30°C. Log phase cultures obtained 
by reculturing stationary overnight cultures were used for all experiments except as 
follows: In one set of experiments, stationary cultures grown overnight or 4 days and a 
stationary culture grown for 4 days and then refreshed for 4 h were used. The reason for 
selecting two different time points for stationary phase cultures was because in some 
studies, C. albicans culture grown overnight or for 48 h was considered to be in 
stationary phase, while other studies reported the stationary phase to start much later, 
for example, between 3 and 8 days (298, 341, 343-349). All broth cultures were 
centrifuged at 3200 rpm for 10 min (centrifuge 5417 C; Eppendorf, Hamburg, 
Germany) and resuspended in PBS. The concentrations were then adjusted by 
measuring optical density (OD 570 of 0.65) to give an approximate cell density of 107	  
colony forming units (CFU)/ml. In one experiment, YPG medium and in another PBS 
with glucose, was used as described above. 
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3.1.3. Experimental design 
The experiments were performed in 35 × 10 mm diameter Petri dishes (BD Falcon NJ, 
USA) containing approximately 3 × 107 cells in 3 ml growth media, PBS with glucose 
or PBS. To examine the effects of different media and glucose on P-Asc sensitivity, 
cells were compared in different growth media; YPD or YPG, or in PBS with glucose. 
YPD or YPG was used both for initial growth and also for P-Asc treatment. Cells were 
agitated/shaken at 157 rpm at 37°C. At each time point two aliquots (10 µl each) were 
withdrawn. One was plated on YPD or YPG agar, the second was added to 90 µl PBS, 
then four additional tenfold dilutions were carried out in a 96 well plate. Subsequently, 
10 µl was transferred from each well on agar plates via drop plate method. Plates were 
incubated between 24 and 48 h in an incubator at 30°C and cell viability was assessed 
by colony counting. In the next experiment cells were treated with P-Asc in PBS with 
agitation at 157 rpm (4 and 37°C); kept at 25 and 37°C under static condition 
(maintained unshaken for the duration of the experiment), or only in PBS with agitation 
at 157 rpm (4 and 37°C). Samples were withdrawn at different time points. 
To determine whether the effect of P-Asc is dependent on the presence of iron, washed 
cells were resuspended in PBS solution with P-Asc, and 2,2′-bipyridyl, an iron chelator 
that predominantly binds Fe2+ (537), was added at a final concentration of 500 µM. 
Subsequently, cells were incubated at 37°C with agitation at 157 rpm, and samples 
withdrawn at different time points. 
3.1.4. Microscopy 
3.1.4.1. Detection of hydroxyl radical generation  
HPF fluorescent probe was added to washed cells and kept in a rotary shaker incubator 
with or without P-Asc in YPD or PBS or kept under static condition at 25°C with P-Asc 
in PBS. Subsequently, cells were spun down (3200 rpm, 3 min),	   supernatant was 
removed and they were resuspended in PBS. Images were acquired using a 35 mm 4-
chamber glass-bottom petri dish (In Vitro Scientific, CA, USA).  
HPF fluorescence images were captured by Olympus FV1000-MPE system with 40X 
NA0.8 water immersion lens. Fluorescence response of HPF was detected with single-
photon excitation at 488 nm using multiline argon laser and the fluorescence emission 
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were collected with laser scanning spectral detector at bandwidth 500–545 nm. 
Brightfield images were acquired simultaneously.  
3.1.4.2. Assessment of intracellular redox status  
Intracellular redox status was measured by autofluorescence imaging of NAD(P)H and 
FAD, using an Olympus FV1000-MPE confocal microscope system with 40X NA0.8 
water immersion lens. The FAD autofluorescence was imaged with single-photon 
excitation at 488 nm using multiline argon laser and the autofluorescence was collected 
with laser scanning spectral detector at bandwidth 500–600 nm. The autofluorescence 
of NAD(P)H was measured with two-photon excitation at 710 nm using MaiTai Deep 
See Ti:Sapphire laser (femtosecond) (Spectra-Physics, MaiTai HP DS-OL). The 
autofluorescence from two-photon excitation was collected with external two-channel 
photo-multiplier detector for NAD(P)H (band-pass filter 420–460 nm). Brightfield 
images were acquired simultaneously.  
3.1.4.3. Transmission electron microscopy  
C. albicans cells were spun down (3200 rpm, 3 min) immediately after treatment, 
supernatant was removed, cells were fixed in 2.5% glutaraldehyde and 2% 
paraformaldehyde, and stored overnight at 4°C. After spinning down (1200 rpm, 10 
min) and decanting the fixative, 0.1 M sodium cacodylate buffer (pH 7.2) was added to 
the pellets. Following fixation, hot agar was added to each pellet. The solidified cell 
pellets were then processed routinely for transmission electron microscopy (TEM). The 
cell pellets were postfixed in 2% OsO4 in sodium cacodylate, dehydrated in graded 
alcohol, embedded in Epont812 (Tousimis, MD, USA). Ultrathin sections were cut on a 
Reichert-Jung Ultracut E microtome (Vienna, Austria), collected on uncoated 200 mesh 
copper grids, stained with uranyl acetate and lead citrate, and examined on a Philips 
CM-10TEM (Eindhoven, The Netherlands) at 80 kV.  
3.1.4.4. Statistics	  	  
Experiments were repeated at least three times. Data points are means and error bars are 
standard deviations. Means were compared for significance (p < 0.05) by one-way 
ANOVA and Bonferroni post hoc test.  
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3.2. Ex-vivo studies on basal cell carcinoma  
3.2.1. Treatment protocol  
We have investigated skin biopsies taken from a 47 year old female patient who 
participated in a pilot study investigating the efficiency of long-term IVA therapy on 
locally advanced basal cell carcinoma. This work was conducted at the Department of 
Dermatology, Venereology and Dermatooncology of the Faculty of Medicine, 
Semmelweis University Budapest, Hungary, in accordance with the ethical standards as 
dictated by the Declaration of Helsinki and informed consent was obtained. 
Compounding of the intravenous vitamin C solution and its off-label use were approved 
by the Regional Committee of National Science and Research Ethics (TUKEB 80/2010) 
and the National Institute for Quality and Organizational Development in Healthcare 
and Medicines (39.798/56/09). Further details regarding patient selection criteria, 
demographic and clinical data can be found in (538). The infusion solutions were 
prepared from concentrated ascorbic acid solutions. Each 50 ml vial contained 25 g 
ascorbic acid (500 mg/ml) and pH was adjusted to 5,5-7 with sodium bicarbonate and 
edetate disodium, as described before (315). Solutions were diluted in 1000 ml Ringer’s 
lactate infusion and administered for the duration of 3 hours by a Port-A-Cath device. In 
general IVA dosage was 1.8 g/kg body weight and it was administered for a total of 173 
sessions.  
3.2.2. Specimen collection and histopathology	  
Skin biopsy samples were taken from two different micronodular lesions after a two-
week drug free interval, and subsequent two weeks of intensive (10 sessions) IVA 
therapy. Hematoxylin and eosin staining was performed on sections from 10% 
formalin-fixed and paraffin embedded skin biopsies.  
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3.2.3. Assessment of tumor collagen environment by second harmonic 
generation and two-photon excitation fluorescence microscopy  
TPEFM and SHG images of deparaffinized tissue samples were acquired by a custom 
modified Axio Examiner LSM 7 MP laser scanning two-photon microscope (Carl Zeiss 
AG, Germany) using a 20X water immersion objective (W-Plan – APOCHROMAT 
20x/1,0 DIC (UV) VIS-IR, Carl Zeiss AG, Germany). We employed a femtosecond 
pulse Ti-sapphire laser (FemtoRose 100TUN NoTouch, R & D Ultrafast Lasers Ltd, 
Hungary) tuned for a 800 nm excitation wavelength and a 395-415 nm band-pass 
emission filter to separate SHG signal from the TPEFM signal, which was collected at 
565-610 nm and intracellularly attributed to mainly FAD (539, 540). The size of each 
field of view corresponded to 0.42 x 0,42 mm, from which mosaic images of larger 
areas up to 6,72 x 6,72 mm were constructed by ImageJ software (NIH, USA). The 
imaging setup is further described in Ref. (534, 541). From the tumor nests and their 
associated peritumoral stroma, five field of views were selected for quantitative 
analysis. Alterations in collagen morphology (fiber length and width) were assessed by 
CT-FIRE (v1.3) (LOCI, USA), a curvelet transform-fiber tracking algorithm in the 
selected field of views (542).  
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4. Results 
4.1. In vitro studies on Candida albicans 
4.1.1. Ascorbate sensitivity of Candida albicans 
4.1.1.1. Effect of different media and carbon source  
We compared the time-dependent killing of P-Asc when the cells were shaken at 37°C, 
suspended either in growth medium YPD or in PBS. Moreover to test whether the 
antifungal activity of P-Asc against C. albicans is altered in different growth media, we 
compared media containing fermentable carbon source dextrose (YPD) or a 
nonfermentable carbon source glycerol (YPG) (543). Figure 3 shows that treatment with 
P-Asc in PBS at 37°C by shaking almost eradicated the cells (>5 logs killing) after 90 
min, while in growth media there was no killing, but rather modest proliferation (up to 
fivefold). Growth media containing fermentable or nonfermentable carbon sources 
made no difference with no fungicidal activity observed in either case. To further 
investigate whether presence of glucose in PBS would have an effect on P-Asc 
sensitivity, we compared cells exposed to P-Asc in PBS with those in PBS-glucose at 
37°C with agitation. Almost two logs of inhibition of killing was observed with added 
glucose at 60 and 90 min (Figure 3).  
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Figure 3: Time-dependent killing of C. albicans with 90 mM P-Asc shaken in phosphate-
buffered saline (PBS), yeast-peptone-dextrose (YPD) medium, yeast-peptone-glycerol (YPG) 
medium or PBS with 20 g/L glucose at 37°C. Controls included shaking in PBS or YPD without 
P-Asc. * p < 0.05, *** p < 0.001. Na ascorb: buffered L-ascorbic acid. 
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4.1.1.2. Effect of oxygenation and temperature  
We compared cells that were treated with P-Asc, in PBS with agitation at 4°C and 37°C 
with those, in PBS under static condition at 25 and 37°C. Control cells were agitated in 
PBS without P-Asc at 4 and 37°C. Figure 4 shows that all three conditions, completely 
abrogated the killing with P-Asc in PBS with agitation at 37°C. It is of interest to note 
that, cells exposed to P-Asc under static conditions formed colonies at a much later time 
when compared with nonexposed cells (data not shown). These findings show the 
importance of both temperature and sufficient oxygenation levels, implying possible 
relevance of active respiration in P-Asc sensitivity.  
	  
Figure 4: Time-dependent killing of C. albicans with 90 mM P-Asc shaken in phosphate-
buffered saline (PBS) at 37°C or 4°C, and not shaken at 37°C or 25°C. Controls included 
shaking in PBS alone at 37°C or 4°C. Na ascorb: buffered L-ascorbic acid. 
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4.1.1.3. Involvement of free iron  
As the literature suggests that iron-catalyzed Fenton reaction is involved in the toxicity 
of P-Asc to tumor cells and infectious microorganisms (229, 316, 544,), we tested the 
effect of a cell-permeable iron chelator 2,2′-bipyridyl, at a final concentration of 500 
µM, on the P-Asc killing of C. albicans in PBS with agitation. There was substantial 
inhibition (>2 logs) of fungicidal activity at time-points between 30 and 90 min (Figure 
5).  
 
	  
	  
Figure 5: Time-dependent killing of C. albicans shaken in phosphate-buffered saline (PBS) at 
37°C with 90 mM P-Asc with or without addition of the iron chelator 2,2-bipyridyl (500 µM). 
** p < 0.01; ***p < 0.001. Na ascorb: buffered L-ascorbic acid. 
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4.1.1.4. Effect of growth history  
We compared the susceptibility of cells coming from early (1 day) and late (4 days) 
stationary phase inoculum, and in the latter case, from refreshed and not refreshed 
cultures, to those coming from log phase, by treating them with P-Asc in PBS with 
agitation at 37°C. Early stationary phase cells (1 day) were the most sensitive, being 
killed 2–3 logs more than log phase cells (Figure 6). Late stationary phase cells (4 days) 
were most resistant, and 4 h refreshing provided more killing only during the first 60 
min of the treatment but not later. 
 
Figure 6: Time-dependent killing of C. albicans taken from cultures at different growth phases 
shaken in phosphate-buffered saline (PBS) at 37°C containing 90 mM P-Asc. Na ascorb: 
buffered L-ascorbic acid. 
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4.1.2. Imaging studies on C. albicans 
4.1.2.1 Detection of hydroxyl radical generation by conventional confocal 
microscopy 
The literature suggests that HO• formation could explain the toxicity of P-Asc (229). 
Thus, we used a highly sensitive and specific fluorescence probe HPF for imaging of 
intracellular HO• generation (545). Figure 7A and B showed no HO• production (green 
fluorescence) when cells were shaken at 37°C either in YPD alone or with P-Asc in 
YPD. Minimal green fluorescence was observed when C. albicans was shaken in PBS 
without ascorbate at 37°C (Figure 7C). More pronounced (but still modest) green 
fluorescence was detected, when the cells were treated with P-Asc in PBS at 25°C 
without shaking (Figure 7D). However, upon 20 min treatment with P-Asc in PBS at 
37°C with agitation there was an intense green fluorescence visible in every cell 
indicating a marked increase in HO•. 
	  
Figure 7: Representative confocal images of HO• generation in Candida albicans after 20 min 
treatment with P-Asc in phosphate-buffered saline (PBS) with or without shaking at 37 and 
25°C, respectively. Cells were stained with 3′-(p-hydroxyphenyl)-fluorescein and images were 
acquired at 40X-zm-6, scale bar = 5 µm. Cells incubated in: (A) yeast-peptone-dextrose (YPD) 
with agitation at 37°C; (B) P-Asc-YPD with agitation at 37°C; (C) PBS with agitation at 37°C; 
(D) P-Asc-PBS under static condition at 25°C; (E) P-Asc-PBS with agitation at 37°C. 
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4.1.2.2. Imaging of intracellular changes in redox state by combination of 
conventional confocal and two-photon excitation fluorescence microscopy 
Intracellular redox state can be observed by detecting the blue (420–460 nm) 
autofluorescence from NAD(P)H, using TPEFM and the green autofluorescence (500–
600 nm) from FAD when excited by single photon (540, 546). In general, healthy cells 
without oxidative stress have high NAD(P)H fluorescence and low FAD fluorescence, 
whereas cells that have been subjected to oxidative stress have lower NAD(P)H and 
higher FAD fluorescence (476, 498, 508). 
Figure 8A and B shows that cells agitated in YPD for 30 min without P-Asc had 
significant amounts of NAD(P)H fluorescence and, no visible FAD fluorescence, 
respectively. Cells in PBS agitated for 30 min without P-Asc, had slightly reduced 
NAD(P)H (Figure 8C) and slightly increased FAD fluorescence (Figure 8D). Cells 
treated with P-Asc at 25°C for 30 min in PBS under static condition showed a 
prominent reduction in NAD(P)H fluorescence (Figure 8E) and a small amount of FAD 
fluorescence appeared (Figure 8F). Cells stirred in PBS with P-Asc for 20 min also 
showed a prominent loss of NAD(P)H fluorescence (Figure 8G), while a substantial 
amount of FAD fluorescence (Figure 8H) was visible. We consider that a slight 
component of NAD(P)H fluorescence may correspond to FAD fluorescence due to the 
minor overlap in their two-photon excitation emission wavelengths (475). Thus the 
NADH signal observed in 20 min is likely to be due to the increased autofluorescence 
of FAD (540). 
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Figure 8: Representative two-photon excitation fluorescence and conventional confocal 
microscopy images of intracellular cell redox changes in C. albicans cells after incubation in 
different culture conditions and treatments. Simultaneous imaging of autofluorescence of 
NAD(P)H (A, C, E & G) and FAD (B, D, F & H). All images were acquired in phosphate-
buffered saline (PBS) at 40X. Scale bar = 5 µM. Cells incubated in: (A-B) yeast-peptone-
dextrose with agitation at 37°C for 30 min; (C-D) PBS with agitation at 37°C for 30 min; (E–
F) P-Asc-PBS under static condition, at 25°C for 30 min; (G–H) P-Asc-PBS with agitation at 
37°C for 20 min. 
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4.1.2.3. Tracking of morphological alterations at the cellular and subcellular level 
by brightfield and transmission electron microscopy 
Fungal vacuoles, resembling mammalian lysosomes are the most acidic compartment of 
the cell with roles such as protein degradation, ionic transport, metabolite and metal ion 
storage as well as detoxification (547). Alterations in vacuolar morphology have been 
reported in response to stress ranging from ionic and acute osmotic shock to long-term 
nutrient deprivation (547). TEM images of C. albicans treated with P-Asc in PBS for 30 
min in a rotary shaker incubator revealed vacuole overgrowth, nuclear condensation as 
well as loss of organelle identity (Figure 9C-D). Consistent with these findings, bright 
field microscopy images showed a similar pattern resembling a peripheral ring with a 
central hole (Figure 9H). Same morphology was also observed in bright field images of 
P-Asc treated cells in PBS at 25°C under static condition (Figure 9G). 
 
 
Figure 9: Transmission electron microscopy (TEM) and brightfield microscopy images of C. 
albicans cells in different incubation and treatment conditions. (A–D) TEM images of C. 
albicans cells following 30 min incubation at 37°C in: (A) yeast-peptone-dextrose (YPD) with 
agitation; (B) phosphate-buffered saline (PBS) with agitation; (C–D) PBS with P-Asc with 
agitation. (A–C) were imaged at 9800X direct magnification, (D) was imaged at 3800X. Scale 
bar = 500 nm. (E–H) Brightfield microscopy images of C. albicans cells following 30 min 
incubation in: (E) YPD with agitation at 37°C (F) PBS with agitation at 37°C; (G) PBS with P-
Asc under static condition at 25°C; (H) PBS with P-Asc with agitation at 37°C. Scale bar 5 µM. 
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4.2. Ex-vivo studies on basal cell carcinoma	  
4.2.1. Label free imaging of tumor collagen environment to assess 
ascorbate’s effect on basal cell carcinoma  
Studies suggest that interactions between tumor cells and extracellular matrix can 
promote cancer progression, and in turn, alterations in peritumoral collagen fibers may 
reveal prognosis or treatment response (519, 521). We evaluated the fine changes of 
collagen in peritumoral stroma of two micronodular lesions, which showed a stable and 
partial response at the end of IVA therapy. In Figure 10c, hematoxylin and eason 
stained tissue reveal typical histologic features of BCC under brightfield microscopy. 
These features such as peripheral palisading cells (yellow) and nests of basaloid cells 
(yellow), are clearly revealed by images acquired by TPEFM (Figure 10a-b). Moreover, 
parallelly aligned collagen fibers (magenta) surrounding the tumor nests could be 
identified by SHG (Figure 10a-b). Of note, TPEFM was utilized only to visualize tissue 
architecture, rather than quantification of tissue characteristics or biochemical 
alterations in intracellular milieu.  
CT-FIRE software is an image processing algorithm that can extract individual collagen 
fibers from acquired SHG images, to quantitatively assess fiber properties such as 
length and width (542). Application of CT-FIRE to SHG images of peritumoral stroma 
revealed that upon intense IVA treatment, thinner and shorter collagen fibers were 
identified (Figure 10 d).  
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Figure 10: (a-b) Two-photon emission fluorescence and second harmonic generation 
microscopy (TPEFM and SHG, respectively) images from the same micronodular basal cell 
carcinoma lesion. a: after a two-week drug free interval, b: after two weeks of intensive (10 
sessions) intravenous high dose ascorbic acid (IVA) therapy. TPEFM signal of FAD is 
displayed in yellow, while SHG signal of collagen fibers is shown in magenta color. (c) 
hematoxylin and eosin stained section corresponding to the TPEFM-SHG image shown in panel 
a. (d) evaluation of mean length and width of collagen fibers from the SHG images before and 
after the abovementioned intensive IVA therapy period assessed by CT-FIRE (LOCI, USA) 
algorithm. 
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5. Discussion 
P-Asc’s selective anticancer and antimicrobioal effect, alone or as an adjuvant, has been 
described in various in vitro and in vivo studies (23, 229, 318, 548). However, these 
findings are not without controversy. The controversy in part stems from the route of 
administration (oral vs intravenous) (309, 311, 549) and the discrepancy between in 
vitro and in vivo studies (229, 317, 318, 550-552). Moreover, P-Asc, due to its reducing 
properties interferes with several conventional assays that rely on oxidation/reduction 
processes (553-556). P-Asc’s exact mechanism of action is yet to be elucidated. To 
date, most commonly suggested mechanism for prooxidant effects of P-Asc has been 
attributed to the formation of Fe2+ and Asc•− by reduction of Fe3+ with AscH− 
(Fe3++AscH− → Fe2++ Asc•−). Reaction of O2 with Fe2+ leads to generation of Fe3+ and 
O2•− (23, 229, 557). A subsequent dismutation of O2•− results in formation of H2O2, 
which in turn undergoes a Fenton reaction with Fe2+`to produce HO• and Fe3+. P-Asc as 
a reductant, can recycle Fe3+ back to Fe2+, thus drive the Fenton reaction (23, 229). A 
second commonly proposed view is that high levels of DHA, the oxidized form of 
AscH−, enter the cells via GLUT channels and, intracellular reduction of DHA to AscH− 
leads to depletion of GSH and NADPH and in turn generate oxidative stress (27, 236). 
Verrax et al. demonstrated that preincubation of tumor cells with deferoxamine 
mesylate, a cell-permeable metal chelator had a protective effect against P-Asc toxicity 
and in contrast, two cell-impermeable iron chelators failed to protect, verifying the 
importance of intracellular metals in P-Asc toxicity (558). Our studies revealed that 
presence of a cell permeable iron chelator 2,2′-bipyridyl hindered killing, which imply 
the involvement of Fenton reaction in antifungal effect of P-Asc on C. albicans (Figure 
5). Notable amounts of HO• detected by conventional confocal microscopy in P-Asc 
treated cells in PBS (Figure 7E) further confirmed this hypothesis.  
Several studies suggest that respiration as well as availability of molecular O2 plays a 
significant role in efficacy of antifungal and antibacterial agents (360, 559, 560). 
Lobritz and colleagues also described that by accelerating basal rate of respiration, 
efficacy of bactericidal drugs can be enhanced (560). As discussed by Fenchel and 
Finlay, because deaeration of liquid media occurs during autoclave sterilization process 
(561) and the diffusion coefficient for O2 into water is extremely low in a static culture, 
cells below ~1 mm grow anaerobically (561, 562).  In addition, static yeast cells tend to 
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sediment rapidly, and in turn uniform oxygenation cannot be maintained. For these 
reasons, agitation/shaking is necessary both for augmenting O2 diffusion into liquid 
media and its equal distribution to cells (561). High level of HO• generation and 
fungicidal activity observed in cells treated with P-Asc in PBS with agitation (aeration) 
(Figure 7E, Figure 4), and the lack of it under static condition (Figure 4) may be 
attributed to this requirement for oxygenation. Moreover, inhibition of killing observed 
in cells treated with P-Asc in PBS with shaking at 4°C (Figure 4) is likely to be due to 
the low metabolic activity, thus lower rate of respiration.  
When cells are exposed to different levels of stress, while some may be killed, or 
damaged, others may show no noticeable phenotypic change (563, 564). In 
microbiology, dormancy often refers to a state in which cells are not able to form a 
colony when plated on an agar medium, but at the same time they are not dead such that 
when conditions are suitable they can return, by resuscitation, to a state of colony-
forming (564). Along these lines, it is notable that C. albicans cells exposed to P-Asc in 
PBS under static condition (Figure 4) may have gone towards a state of early apoptosis 
considering that there was no loss of viability by CFU determinations, but only a delay 
in colony formation (data not shown) (565). Oxidative damage, shown by slight 
generation of HO• (Figure 7D), attenuated signal of NAD(P)H (Figure 8E) and 
morphological changes observed by a peripheral ring with a central hole in bright field 
microscopy (Figure 9G), was probably repaired by the still active antioxidant defense 
system of these cells.  
When glucose as a carbon source was added into PBS in the absence of nitrogen, P-Asc 
killing was partially inhibited (Figure 3). As previously mentioned, presence of glucose 
increases resistance to oxidative stress (369). For instance, transient exposure to glucose 
was shown to protect cells from H2O2 and also from miconazole, an azole antifungal 
drug (369). Apart from upregulation of genes involved in stress response, a metabolic 
shift to the glycolytic pathway and reduced activity of electron transport chain, may also 
be involved in this process (369, 566). In addition, generation of sufficient levels of 
NADPH through pentose phosphate pathway may restore cellular antioxidant capacity 
eg. by facilitating regeneration of GSH. Yeast cells presumably uptake P-Asc through 
glucose (hexose) transporters (567-569). An alternative explanation could be the 
diminished uptake and in turn diminished P-Asc concentration in cells due to saturation 
of hexose channels by the presence of glucose.  
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To date, C. albicans stress responses have been mainly studied on cells cultured in rich 
glucose-containing media, but such environments are significantly different from host 
microenvironments, which are mostly glucose-limited, heterogenous and complex 
(366). For instance, while glucose levels in blood and vaginal secretions are around 
0,8% and 0,5%, respectively, glucose content in one of the commonly used nutritious 
media, YPD is 2% (365-367). In an attempt to understand variations in, in vitro and in 
vivo activity of P-Asc, sensitivity of C. albicans cells to P-Asc was tested in different 
media containing fermentable carbon source dextrose (YPD), nonfermentable carbon 
source glycerol (YPG) (543) and PBS, under aeration (shaking). No reduction in 
number of CFU was observed when the cells were treated in either nutrient rich growth 
media (Figure 3). Inhibition of killing observed in YPD media is partially due to 
presence of glucose, because the same amount of glucose introduced in PBS, hindered 
cytotoxic effects of P-Asc. Moreover, peptone, present in both YPD and YPG, is a 
source of carbon, nitrogen, vitamins and minerals and as known, the initial two are the 
major sources for biosynthetic processes and energy. Therefore, depleted cellular 
metabolic products and enzymes caused by prooxidant effects of P-Asc may be 
compensated by the abundant supply of substrates present in the nutrient rich growth 
media. Nevertheless, YPD and YPG are considered as complex mediums with 
undefined compositions, therefore unknown interactions may have also taken place 
between the media components and P-Asc that in turn increase its consumption and/or 
reduce its activity. 
Literature suggests that, growth history plays an important role in fungi cells’ response 
to new conditions such as starvation or oxidative stress (345, 570). In general, cells in 
stationary phase are more tolerant to stress conditions than those in the logarithmic-
growth phase (341). Although exact timing of entry into stationary phase is not clearly 
defined (298, 341, 343-349), several distinct features such as drug resistance, DNA 
repair, cell wall biosynthesis, virulence gene expression, and gluconeogenesis have been 
attributed to the stationary phase (341).  Whilst some studies consider a C. albicans 
culture grown overnight or for 48 h to be in stationary phase (348, 349, 571, 572), 
others report this phase to start at a much later time, e.g. between 3 and 8 days (341, 
347, 573-575). Based on these reports, we investigated whether cells exposed to P-Asc 
in PBS with aeration (agitation) demonstrated growth history and phase dependent 
sensitivity and, we defined 1 day cultures as early stationary phase and 4 day cultures as 
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late stationary phase. The cells were more sensitive to P-Asc when they were in early 
stationary phase or in a log phase inoculum than, those that come from a late stationary-
phase inoculum (Figure 6). These findings are in agreement with Uppuluri and 
Chaffin’s study in which the group reported higher expression of oxidative stress 
resistance genes at 3 days and beyond (341).  
Intracellular autofluorescence is usually dominated by NAD(P)H and FAD, both of 
which are indicators of intracellular redox state and metabolic activity (476, 540, 546, 
576). Elevations in FAD autofluorescence were shown to be correlated with markers of 
apoptosis and oxidative stress (476, 508, 577, 578). Conversely, remarkable reduction 
in NAD(P)H and GSH signals were observed when cells encountered high levels of 
ROS (498, 508). Our results demonstrated that, cells exposed to P-Asc in PBS for 30 
min under static condition resulted in almost total depletion of NAD(P)H together with 
a slight increase in FAD autofluorescence intensity (Figure 8E-F), whereas same 
treatment for 20 min by shaking, led to a similar attenuation in NAD(P)H signal but this 
time together with a rapid strong increase in FAD autofluorescence (Figure 8G-H). 
Increased oxidative stress, denoted by increased HO• is most likely responsible for the 
shift in overall cellular redox state of C. albicans (Figure 7D-E). In addition to ROS, 
generated by Fenton reaction, recycling Asc•− and DHA to AscH− may also consume 
significant amounts of NAD(P)H and GSH (23, 231, 229, 236). This would in turn 
result in depletion of cellular antioxidant capacity, enhalt ATP production, and lead to a 
cellular energy crisis (231).  
Fungal vacuoles are acidic organelles with detoxification function and, degradative and 
storage capacities like mammalian lysosomes (547, 579). They are considered as the 
major storage compartment for amino acids, phosphate, and many metal ions (547, 
580). Vacuoles also have a significant role in responding to various stresses such as 
nutrient deprivation, ionic and osmotic stress. For instance, they regulate iron 
homeostasis by altering expression of iron transporters in response to new conditions 
such as oxidative stress and iron deprivation (547, 581-583). In response to stress, 
changes in vacuole morphology are observed. Whilst actively metabolizing log phase 
cells have 2-3 medium sized vacuoles, during stationary phase or with glucose 
deprivation these vacuoles merge and form a single large vacuole (547). In this study, 
we compared morphological modifications in C. albicans by brightfield microscopy and 
TEM to elucidate the effect of P-Asc on intracellular organells. When cells were 
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exposed to P-Asc in PBS (with or without agitation), the most prominent feature was a 
deflated ball like morphology observed in majority of the cells (Figure 9G-H). These 
cells exhibited a large central depression with a peripheral ring. To further investigate 
and confirm this observation, we compared cells incubated in nutritious growth media, 
PBS and PBS with P-Asc (all with agitation) by TEM (Figure 9A,B,C,D). In cells 
treated with P-Asc in PBS, small electron dense vacuoles were replaced with a large 
electron lucent vacuole and this morphological change was also accompanied by loss of 
organelle structure (Figure C-D). 
Studies suggest that modifications in collagen structure and orientation in tumor stroma 
can provide insights into tumor development, progression and/or metastasis (501, 526, 
539). Sapudom and colleagues showed that breast cancer invasiveness increased with 
increasing collagen fiber thickness (521). Likewise, Drifka et al. described increased 
collagen width around malignant ducts of pancreatic ductal adenocarcinoma (530). On 
the other hand, a recent study by Kiss et al. have demonstrated that tumor stroma of 
BCC lesions had reduced SHG signal intensity and fiber angle, higher allignment of 
collagen fibers, increased collagen fiber length but similar collagen width and 
straightness (534). When majority of these findings are taken into account, reduced 
peritumoral collagen fiber length and width after intense IVA therapy (Figure 10d) is 
suggestive of response to therapy, which can be monitored by SHG. Nevertheless, small 
sample size used in this study warrants further studies with larger sample size and 
validation. 
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6. Conclusion 
In order to address seemingly contradicting results from various studies investigating 
prooxidant effects of P-Asc and understand the conditions in which P-Asc shows 
antifungal activity against C. albicans, we have conducted our studies in different 
experimental settings and employed various optical imaging tools to assess its effects. 
According to our results, it is evident that some of the conflicting findings are due to the 
variations in cell metabolism and environment in vitro and in vivo conditions. P-Asc’s 
efficacy as a prooxidant depends on oxygenation, temperature, access to nutrition, 
presence of iron and cell growth history. Therefore, inter- and intra-host heterogeneity 
in infections and, inter- and intra-tumor heterogeneity in cancer cells as well as their 
types should be taken into account while considering P-Asc as a prooxidant. Moreover, 
in the light of these findings, therapeutic response may be augmented by addition of 
vasoactive agents or hyperoxic gas mixtures. In an attempt to further elucidate 
mechanistic insights into P-Asc’s prooxidant effects, we employed various optical 
imaging modalities, some of which can potentially serve as real time monitoring tools 
for treatment response. To the best of our knowledge, we demonstrated for the first time 
that intracellular HO• generation by P-Asc is an active participant in oxidative damage 
to cells. Consistent with this finding, simultaneous label-free live cell imaging with 
TPEFM and conventional confocal microscopy revealed a marked reduction in 
NAD(P)H and elevation in FAD+ levels, respectively, the latter mainly in dying cells. 
Concomitantly, a vacuolar enlargement was captured by TEM, and coincided with the 
deflated ball appearance seen in brightfield microscopy.  
Ex-vivo imaging studies were performed with TPEFM and SHG using limited number 
of skin biopsy samples taken from basal cell carcinoma lesions. Results indicated that 
IVA therapy alters tumor collagen environment. These novel label free optical imaging 
tools may enable real time in vivo evaluation of treatment response and eliminate 
biopsy as well as routine staining processes. 
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7. Summary 
The discovery of hexanuric acid, later renamed as L-ascorbic acid, by the 1937 Nobel 
Prize laureate Albert Szent-Györgyi was a milestone in the expanding and 
multidisciplinary field of antioxidants. The second turning point in the history of 
ascorbic acid began in 1970s, when first reports appeared describing its potential effects 
against common cold and cancer. Since then, pharmacologic use of ascorbic acid as a 
prooxidant (P-Asc), especially at high doses became the subject of a long-standing 
controversy. Some of this controversy stems from experimental methodology, 
fundamental differences between in vitro and in vivo conditions and tissue 
heterogeneity, which in part results from environmental distinctions. Literature 
regarding antifungal effects of P-Asc against Candida albicans is sparse and 
inconclusive. In addition, its exact mechanism of action is not yet fully elucidated. In an 
attempt to gain mechanistic insights, understand the conditions in which P-Asc exerts its 
prooxidant effects and, circumvent some of the limitations arising from the 
experimental methodology, we investigated the effect of P-Asc under different 
experimental conditions and exploited various optical imaging tools. Our results 
demonstrated that, growth history of cells, their access to nutrition, oxygenation, 
temperature, presence of transition metal ions are all important factors that need to be 
taken into consideration. On the other hand, intracellular hydroxyl radical generation 
seems to play an important role in oxidative stress generated by P-Asc. In parallel with 
this finding, simultaneous label-free live cell imaging with two-photon emission 
fluorescence microscopy (TPEFM) and conventional confocal microscopy revealed a 
marked reduction in NAD(P)H and elevation in FAD levels, respectively, the latter 
mainly in dying cells.  
Combining TPEFM with second harmonic generation microscopy and an advanced 
image analysis technique enabled us to assess fine changes of tissue pathology during 
intravenous P-Asc (IVA) therapy of basal cell carcinoma (BCC), which were not 
apparent in standard hematoxylin and eosin stained histology sections. The results of 
our ex-vivo study with limited skin biopsies taken from BCC lesions revealed that IVA 
therapy alters tumor collagen environment. These morphological alterations could be 
exploited to monitor real time label free in vivo evaluation of treatment response 
without any need for biopsies.  
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8. Összefoglalás 
Az 1937-ben Nobel-díjat nyert Szent-Györgyi Albert által felfedezett henaxuronsav, 
későbbi nevén L-aszkorbinsav mérföldkő volt az antioxidánsok egyre jobban fejlődő és 
később multidiszciplinárissá váló területén. Az aszkorbinsav történetében bekövetkező 
második fordulópont az 1970-es évekre tehető, ekkor jelentek meg először a megfázás 
és a daganatok elleni potenciális hatásáról szóló publikációk. A nagy dózisban adott 
aszkorbinsav mint prooxidáns hatóanyag (P-Asc) gyógyszerként való használata 
ugyanakkor régóta tartó ellentmondás tárgya. Az ellentmondások részben a kísérletes 
módszertanok eltéréseiből, az in vitro és in vivo körülmények alapvető 
különbözőségéből és a szöveti heterogenitásból erednek, melyek részben a környezeti 
különbségek eredményei. Az irodalmi adatok a P-Asc Candida albicans elleni 
antifungális hatásáról szegényesek és nem meggyőzőek. Emellett a pontos 
hatásmechanizmus sem volt ezidáig teljesen tisztázott. A P-Asc prooxidáns hatásának és 
hatásmechanizmusának jobb megértéséhez, azért hogy kizárjuk a kísérletes 
módszertanból adódó különbségeket, eltérő kísérletes körülmények között különböző 
optikai képalkotó eszközök használatával végeztünk vizsgálatokat. Eredményeink azt 
mutatták, hogy a sejtek növekedésének üteme, a tápanyagokhoz való hozzáférése, az 
oxigenizáció, a hőmérséklet, valamint az átmeneti fémek ionjainak jelenléte mind 
jelentős faktorok, melyeket mind fontos figyelembe venni.   
Másrészről az intracelluláris hidroxilgyök-termelődésnek is fontos szerepe lehet a P-Asc 
által generált oxidatív stresszben. Ezzel az eredménnyel egybevágott a festékjelölés-
mentes sejtes képalkotás kétfoton fluoreszcencia mikroszkópiával (TPEFM) illetve 
konvencionális konfokális mikroszkópiával végezett vizsgálatának eredménye, jelentős 
csökkenést mutattak a NAD(P)H, valamint emelkedést a FAD szintek, utóbbi főként a 
pusztuló sejtekben volt megfigyelhető.  
 
A TPEFM másodharmonikus keltéses mikroszkópia és a fejlett képfeldolgozó 
módszerek kombinációja lehetővé tették a szöveti patológia finom változásainak 
elemzését bazálsejtes carcinoma (BCC) intravénás P-Asc (IVA) terápiája mellett, 
melyek hagyományos hematoxilin-eozin festéssel nem tehetők láthatóvá. Az ex-vivo 
tanulmány limitált számú, BCC léziókból származó bőrbiopsziás mintáinak eredménye 
azt mutatatja, hogy az IVA kezelés befolyásolja a tumor kollagén környezetét. Ezen 
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morfológiai változások felhasználhatók a terápiás válasz real-time festékjelölés-mentes 
in vivo monitorozására, így a kontroll bőrbiopsziás mintavétel szükségtelenné válhat.  
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